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Abstract 
Degenerative diseases of the retina, especially age-related macular 
degeneration (AMD) have profound effects on vision and thus significantly impair 
quality of life. Currently, the only treatment available for AMD patients involves the 
intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents 
that can help to modulate aberrant vascular growth. However, this symptom affects 
only 15 % of AMD patients. Furthermore, the anti-VEGF agents do not repair 
structural changes that occur as a result of the natural history of AMD progression. 
The structural changes originating in three tissue layers known as Ruysch’s complex, 
have been linked to a number of local and systemic complications, that can result in 
monocular and bilateral blindness. Theoretically, the replacement of these three 
tissue layers, namely the retinal pigment epithelium (RPE), the acellular Bruch’s 
membrane, and the choriocapillaris would be the best therapeutic option for all AMD 
patients as it would reconstruct the subretinal architecture. The development of cell-
based therapies for the treatment of degenerative retinal diseases has therefore 
attracted much interest within the fields of ophthalmology and regenerative 
medicine. 
Ideally, a cultured tissue substitute would include a functioning monolayer of 
RPE, a suitable biomaterial substitute for Bruch’s membrane (thin, mechanically 
strong and permeable) and choroidal vascular endothelial cells that could anastomose 
with the patient’s vasculature, helping to anchor the complex upon implantation. A 
major hurdle in the development of a cell-based therapy is the identification of an 
appropriate biomaterial substitute for Bruch’s membrane. Recently Bombyx mori silk 
fibroin (hereafter referred to as fibroin) membranes, made to a similar thickness as a 
healthy Bruch’s membrane (3 µm), have been found to support the attachment and 
growth of RPE cells (Shadforth et al., 2012). Thus this thesis aims to explore the 
feasibility of using fibroin membranes as a biomaterial substitute in the 
reconstruction of Ruysch’s complex. The project set out to evaluate the functionality 
of RPE cells grown on fibroin membranes, evaluate the feasibility of modifying 
fibroin membranes to include extracellular matrix (ECM) components vital to the 
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native structure of Bruch’s membrane, and establish a co-culture model of Ruysch’s 
complex in vitro. 
 In the first research study (Chapter 3), the human cell line ARPE-19 was used 
to establish confluent cultures of RPE cells on fibroin membranes and were 
maintained under conditions designed to promote maturation. As a control, parallel 
cultures were established and maintained to maturity on commercial porous polyester 
cell culture well inserts (Transwell
®
), the current gold standard epithelial culture 
substrate. Cultures established on both materials were examined for evidence of 
trans-epithelial resistance (TER), features of RPE cell morphology and metabolism, 
specific phagocytic function (via uptake of vitronectin-coated microspheres) and 
apical/basal growth factor secretion. Cultures established on either material 
developed a cobblestoned morphology with partial pigmentation within 12 weeks, 
however, cultures grown on fibroin displayed a rounder apical surface with a more 
dense distribution of microvilli-like projections. Negligible change in TER was 
observed for cultures grown on either material, however this result is in keeping with 
prior studies of ARPE-19 cell function. Examination by immunocytochemistry, at 16 
weeks, revealed a generally similar distribution pattern for RPE-specific cytoplasmic 
and membrane-bound proteins. Cultures grown on either material displayed specific 
phagocytic function and polarised secretion of growth factors was routinely detected 
in the conditioned medium collected from above and below both membrane types. 
These findings demonstrated that RPE cell functions on fibroin membranes are 
equivalent to those observed for standard test materials (polyester membranes).  
 After confirming RPE functionality on fibroin membranes, focus was shifted 
to the native structure of Bruch’s membrane, namely its central core of elastin 
(Chapter 4). The specific structural and functional roles the Bruch’s membrane fulfils 
within the outer retina, creates a complex list of requirements for a biomaterial 
substitute. This thesis evaluated the feasibility of incorporating an elastin component 
to the fibroin membranes. It was hypothesized the modified fibroin membranes may 
provide a potential delivery vehicle for both RPE cells and ECM components into 
diseased or injured tissues. Two basic strategies were explored: (1) membranes were 
prepared from blended solutions of fibroin and tropoelastin, or (2) layered constructs 
were prepared from sequentially cast solutions of fibroin, tropoelastin and fibroin. 
The retention of tropoelastin within blend and layered constructs was confirmed by 
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immunolabelling and Fourier-transform infrared spectroscopy (FTIR). The RPE cell 
response to fibroin membranes was not affected by the presence of tropoelastin. 
Interestingly, blend membranes displayed superior strength and elasticity when 
compared to the layered constructs, however, the standard fibroin membranes and the 
layered constructs demonstrated a Young’s modulus in the range of a healthy 
Bruch’s membrane. Further work will be required to optimise the interaction 
between the two proteins, however, the findings of this study support the potential 
use of fibroin membranes for the co-delivery of RPE cells and tropoelastin. 
 In the final research study (Chapter 5), a co-culture model of Ruysch’s 
complex was developed in vitro, using the fibroin membranes as a substitute for 
Bruch’s membrane. This study demonstrated that the fibroin membrane was able to 
act as a physical barrier between the two cell types, while facilitating communication 
between the mature monolayer of RPE cells and the choroidal-derived vascular 
endothelial cells that were seeded within a collagen type I gel. The fibroin 
membrane, suspended in our custom-designed culture chamber, was able to support 
the three-dimensional collagen gel for the entirety of the culture period and the co-
culture complex could be described as being an in vitro representation of the 
subretinal architecture. Further refinement and development of this co-culture 
complex could provide insights into the mechanisms of interaction between the two 
cell types, and its use as a model of AMD disease will likely be the ultimate test of 
function, prior to pre-clinical trials.  
The implantation of fibroin membranes into an animal model to study safety, 
efficacy and surgical handling will be ultimately paramount to understand the 
immunogenicity and degradation rate of fibroin membranes in the subretinal space. 
The tissue engineered complex developed in this project is in many ways comparable 
to Ruysch’s complex, however, considerable future efforts will be required to create 
an implant suitable for human patients. The outcomes described in this thesis provide 
a foundation for the use of fibroin membranes as a Bruch’s membrane substitute and 
offer a stepping stone for future studies in RPE transplantation. 
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Chapter 1: Introduction 
1.1 DESCRIPTION OF RESEARCH PROBLEM INVESTIGATED 
Retinal degeneration, especially AMD, is a leading cause of blindness in the 
Western world. Patients suffer from extensive visual impairment due to degenerative 
change in the retina and its adjacent layers, loss of functioning cells, abnormal 
vascular ingrowth, and subsequent scar formation at the macula. Cell transplantation 
has been explored, with limited success, as a potential treatment and one of the 
reasons for this lack of success is the lack of a suitable substratum as support for the 
cells to be transplanted.  
Globally, AMD is estimated to affect almost 8 million people (Gordois et al., 
2012). In Australia, it is the most common (56.9%) cause of blindness (presenting 
visual acuity of less than 6/60) and is primarily seen in older people. It is predicted 
that in the coming decade the number of Australians who will have low vision or lose 
their sight will double to almost 1 million people (Hong et al., 2013). The direct 
health cost of AMD worldwide was approximately US$300 billion in 2010 (Gordois 
et al., 2012). Having no curative treatment for AMD means the need for resources 
will continue to increase with ongoing care requirements. Patients, caregivers, 
doctors, and society in general carry a substantial economic burden when considering 
the consequences of AMD (Köberlein et al., 2013). Vision loss caused by AMD can 
affect one or both eyes and this causes a significant impact on the emotional 
wellbeing of patients (Williams et al., 1998). The loss in independence, participation 
in society and overall quality of life, can exacerbate a functional decline in patients, 
resulting in depression, increased incidence of falls and injuries, and the 
consequential physical and financial burdens (Köberlein et al., 2013). It is estimated 
3.4 million ‘healthy life years’ were lost globally due to AMD in 2010 (Gordois et 
al., 2012). 
The use of anti-VEGF agents for treatment of the neovascular (wet) form of 
AMD has revolutionized the prognosis of this devastating condition. Stabilisation 
(even improvement) of vision is a common outcome of this therapy option. 
Unfortunately, anti-VEGF therapy is accompanied by a significant treatment burden; 
examinations, evaluations, and intravitreal injections need to be performed on a 
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monthly schedule for best visual outcomes (Lanzetta et al., 2013). Additionally, 
complications have been associated with continuous use of anti-VEGF drugs 
delivered by intravitreal injection. These adverse events, unrelated to the underlying 
ocular disease, include potentially serious intraocular bacterial infection 
(endophthalmitis), acute intraocular inflammation, retinal detachments and sustained 
elevated intraocular pressure that may require anti-glaucoma treatments (Falavarjani 
& Nguyen, 2013). Non-ocular haemorrhage and systemic wound-healing issues have 
also been reported with continuous anti-VEGF treatments (Bodnar, 2014). Moreover, 
anti-VEGF therapies do not address the broader pathology of AMD involving the 
degenerative structural changes in the outer retina. 
The primary problem is that a biomaterial which mimics the native thickness 
and mechanical properties of Bruch’s membrane, supports RPE cell function, and 
could be implanted and left in the subretinal space as a Bruch’s membrane prosthesis 
is yet to be identified. The evaluation of novel biomaterials that could be used in this 
context for RPE transplantation is an ongoing area of research that is required for the 
development of a viable treatment option for a devastating disease that affects our 
ageing population.  
 
1.2 DEFINITIONS AND KEY CONCEPTS 
Outer retina – classification is defined by metabolic blood supply from the 
choroidal vasculature.  Typically the outer retina is described as the photoreceptors, 
the retinal pigment epithelium, Bruch’s membrane and the choriocapillaris.  
Ruysch’s complex – a historical term for the three tissue layers between the 
photoreceptors and the choroidal vasculature. These three layers are the retinal 
pigment epithelium, Bruch’s membrane, and the microvascular choriocapillaris.  
Retinal pigment epithelium (RPE) – a monolayer of pigmented epithelium that 
makes up the outermost layer of the sensory retina and supports the metabolic 
function of the photoreceptor cells. 
Bruch’s membrane – an extracellular matrix structure, rested on by the basal 
surface of the RPE monolayer, which acts as a molecular sieve and supports the 
functions of the RPE and the choriocapillaris. 
Choriocapillaris – the microvascular component of the multilayered choroidal 
vasculature. The choriocapillaris is a fenestrated network of capillaries, not unlike 
 Introduction 23      
the glomerulus of the kidney, which is structurally and functionally vital to RPE and 
photoreceptor cell survival.  
RPE transplantation – due to the important functions performed by healthy 
RPE in support of the photoreceptor cells of the sensory retina, and the age-related 
changes that occur in this pigmented monolayer, it is theorised that removing the 
aged RPE and replacing them with new, fresh RPE cells will halt any further 
photoreceptor degeneration, preventing blindness. Unfortunately, the transplantation 
of RPE into human patients with appropriate clinical improvements in vision has 
proven more complex. The current theory is that RPE cells will need to be 
transplanted as a functioning monolayer on a biomaterial substrate.     
Bruch’s membrane prosthesis – a theory proposed by Professor Susan Binder 
and colleagues in 2007 (Binder et al., 2007), which requires an appropriate 
biomaterial substrate to act as a support for the culture of RPE cells in vitro, as well 
as act as a Bruch’s membrane substitute upon transplantation for as long as needed, 
possibly indefinitely. 
 
1.3 OVERALL OBJECTIVES OF THE STUDY 
The overall objective of the study is to evaluate fibroin as a biomaterial of 
choice in the development of a cultured tissue substitute, which mimics Ruysch’s 
complex, in the context of RPE transplantation. This is a fundamental step in the 
development of a viable therapeutic treatment, for diseases such as AMD. The novel 
biomaterial evaluated in this study was derived from fibroin, the structural protein 
isolated from the cocoon of the Bombyx mori silkworm.  
The scope of this research study was confined to the development and 
evaluation of an in vitro cell culture study, which used immortalised cell lines and 
the observation of morphological features that would be consistent with biological 
functioning. The evaluation of fibroin as a biomaterial in this context however, 
informs future studies that could use more appropriate RPE cell sources suitable for 
RPE transplantation (autologous human RPE, and induced pluripotent stem cell-
derived RPE), as well as provides a novel contribution to the literature on the 
suitability of fibroin as a Bruch’s membrane prosthesis.  
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1.4 SPECIFIC AIMS OF THE STUDY 
1. To examine RPE cell functionality when grown on fibroin membranes 
2. To use different methods to incorporate an elastin component in 
fibroin membranes 
3. To co-culture RPE and choroidal-derived vascular endothelial cells 
either side of fibroin membrane 
 
1.5 HYPOTHESES 
1. We hypothesise that fibroin membranes will support RPE cell 
functionality. 
2. We hypothesise that the incorporation of an elastin layer/component 
will improve the functionality of fibroin membranes and allow it to 
better mimic native Bruch’s membrane.  
3. We hypothesise a co-culture system will be supported by a fibroin 
membrane, and there will be a functional/morphological advantage to 
the tri-layer construct in the context of RPE transplantation. 
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Chapter 2: Literature Review 
2.1 RUYSCH’S COMPLEX AND ITS IMPORTANCE TO VISION 
Ruysch’s complex is a historical term used to describe three layers of the outer 
retina between the photoreceptor outer segments and the choroidal vasculature (Fig. 
2.1). The three layers of Ruysch’s complex are the retinal pigment epithelium (RPE), 
Bruch’s membrane, and the microvascular choriocapillaris (de Jong, 2006) 
 
 
Figure 2.1. A schema of the eye demonstrates the principal refractive elements of the 
visual pathway, the cornea (A) and the lens (B). The retina (C) lines the internal 
posterior surface of the eye and contains the sensory components of the visual 
pathway. A histological preparation (D) reveals the proximity of the photoreceptor 
outer segments (OS) to the retinal pigment epithelium (RPE), and the underlying 
Bruch’s membrane (BrM) and choriocapillaris (Ch). These three layers (RPE, BrM 
and Ch) are collectively named Ruysch’s complex. Source: D.G. Harkin. 
2.1.1 Retinal Pigment Epithelium 
The RPE is a monolayer of pigmented cells derived from the neuroectodermal 
layer of the optic cup and constitutes the outermost layer of the sensory retina. The 
metabolic activities of the RPE are vital for the local homeostasis and maintenance of 
the overlying photoreceptors and the underlying blood supply, the choroidal 
vasculature. The unique and specialised functions performed by the RPE (Fig. 2.2), 
include the directional transport of nutrients and waste, daily phagocytosis of shed 
photoreceptor outer segments, regeneration of the Vitamin A-based chromophore 
required in the visual cycle, and polarised secretion of growth factors (Strauss, 2005). 
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The RPE cell exhibits an apical–basal polarity characteristic of a transporting 
epithelium, with apical tight junctions binding neighbouring RPE cells together to 
form the outer blood-retinal barrier (Rizzolo, 1997). This barrier induces 
transcellular transport and in conjunction with asymmetrical membrane protein 
distribution, allows directional transport of glucose, retinol (Vitamin A) and fatty 
acids to the photoreceptors. Equally important, this active transport process removes 
ions, metabolic waste products and water from the subretinal space (Strauss, 2005). 
The removal of water from the subretinal space is vital for photoreceptor health 
(Marmor, 1998). Furthermore, the highly folded basal membrane of the RPE helps to 
increase the surface area required for absorption and secretion. 
The RPE cells extend apical microvilli into the subretinal space and ensheathe 
the photoreceptor outer segments. The apically localised transmembrane integrin, 
αVβ5, mediates retinal adhesion and promotes circadian-controlled phagocytosis of 
shed outer segments (Nandrot et al., 2006). Once engulfed, the segments are broken 
down by lysosomal activity within the RPE cell. This process is integral to the visual 
cycle, allowing the regeneration of the Vitamin A-based chromophore, trans-retinol, 
using the RPE-specific cytoplasmic isomerohydrolase, RPE-65 (Strauss, 2005). The 
chromophore, oxidised to 11-cis-retinal, is bound to the cellular retinaldehyde-
binding protein (CRALBP), before being released by the RPE cell to be taken up by 
the photoreceptors. Mutations in the phagocytic signalling protein MER proto-
oncogene tyrosine kinase, commonly referred to as MerTK, the cytoplasmic 
isomerase RPE-65, or the binding protein CRALBP induce significant pathology of 
the photoreceptors, as seen in retinitis pigmentosa (Travis et al., 2007). 
  Interestingly, geographical differences can be seen in RPE cells. In the 
macula, for example, RPE cells are small and tightly packed (14 µm × 12 µm/cell). 
By contrast, peripheral RPE cells, are relatively larger (60 µm/cell) and variable in 
height (Strauss, 2005; Harman et al., 1997; Panda-Jones et al., 1996). As the RPE 
cells in the macula are densely packed, the area appears darker (Feeney-Burns et al., 
1984). The melanin granules within the RPE cytoplasm help to absorb radiant energy 
focused by the lens onto the retina, which is beneficial to visual acuity by preventing 
light reflection and dispersed light from interfering with the signal received by the 
photoreceptors (Boulton, 1998). The intense heat generated in this area is dissipated 
by the choroidal perfusion. It has also been shown that RPE cells of the macula 
 Literature Review 27      
demonstrate higher degradation enzyme activities allowing for the maintenance of 
greater numbers of macular photoreceptors compared with RPE cells in the 
peripheral retina (Strauss, 2005). 
Photoreceptor and vasculature health is maintained by polarized secretion of 
various trophic factors by the RPE. In particular, the secretion of vascular endothelial 
growth factor (VEGF) and pigment epithelium derived factor (PEDF) by the RPE 
has been implicated in the maintenance of photoreceptor health, immune privilege 
and the integrity of the surrounding vasculature (Kay et al., 2013; Strauss, 2005).  
2.1.2 Bruch’s membrane  
The highly folded basal membrane of the RPE rests on Bruch’s membrane, a 
collagen- and elastin-rich extracellular matrix structure (Booij et al., 2010). Stacked 
linear elastin fibers form a perforated sheet that is interposed between grid-like layers 
of collagen. The basement membranes of the RPE cells and the choriocapillaris 
endothelium basement membrane complete the pentalaminar structure (Marshall et 
al., 1998). 
Bruch’s membrane acts in support of the outer blood-retinal barrier, as a semi-
permeable sieve. The organisation of each fibrous layer forms an arrangement of 
pores (Marshall et al., 1998). Movement through Bruch’s membrane is primarily 
passive and molecules less than 70 kDa in size are able to diffuse freely (Booij et al., 
2010). As stated earlier, photoreceptor health relies on the apical to basal removal of 
water from the subretinal space by the RPE, returning it to the general circulation. 
The unobstructed movement of nutrients, water and waste products through Bruch’s 
membrane is vital for retinal health (Marshall et al., 1998). 
Located between the RPE and its blood supply, Bruch’s membrane is under 
pressure-induced stress oscillating with cardiac rhythm (Bonilha, 2008). It has been 
suggested that the central layer of elastin in Bruch’s membrane, may act as a 
dampener to the pulsations of the choroidal vasculature that could potentially disrupt 
the RPE and photoreceptor outer segments (Leure-duPree, 1968). There is debate as 
to the origin of Bruch’s membrane during development. The RPE and choroid are 
capable of synthesizing most of the extracellular components (Booij et al., 2010; 
Campochiaro et al., 1986); however the source of the elastin layer is still a matter for 
investigation (Strauss, 2005).   
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2.1.3 Choriocapillaris 
The vascular structure that directly underlies Bruch’s membrane is called the 
choriocapillaris. It is the innermost layer of the choroidal vasculature and is the 
metabolic blood supply of the RPE and photoreceptors (Strauss, 2005). The 
choriocapillaris is a network of continuous capillaries arranged in fan-shaped or 
triangular lobules that create a mosaic pattern enface to Bruch’s membrane (H. R. 
Zhang, 1994). The structural integrity of the choriocapillaris, including the formation 
of fenestrations on the RPE side of the vascular endothelial cells, is maintained 
directly by growth factors secreted by the RPE (Kay et al., 2013). The vascular 
anatomy of this dense capillary network, especially at the posterior pole, forms a 
segmental blood supply that can support large quantities of blood at a high flow rate 
(H. R. Zhang, 1994). The choriocapillaris is often compared to the glomerular 
capillaries of the kidney, however the choriocapillaris has a blood flow 4 times 
higher than the kidney, and 28 times higher than the brain (Boron & Boulpaep, 2009; 
Strauss, 2005). Consequently, the subretinal area is an extremely oxygen-rich 
environment. 
2.2 AGE-RELATED CHANGES AND THE INFLUENCE ON VISION 
HEALTH 
Structural changes occur in Ruysch’s complex with age. These changes include 
the accumulation of debris within the cytoplasm of the RPE cell, as well as 
deposition of sub-RPE deposits. There is also a breakdown in the barrier and 
transport capacity of Bruch’s membrane and a reduction in the density and integrity 
of the choriocapillaris (de Jong, 2006). Human RPE cells display limited mitotic 
activity from two years of age, and degenerative changes tend to accumulate with 
age. Age-related changes can typically be seen in RPE cells with the atrophy of 
apical microvilli, disorganization of basal infoldings, the disappearance of melanin 
granules, and partially digested residues begin to clog the cytoplasm (Bonilha, 2008). 
One particularly obvious age-related change within the RPE is the 
accumulation of lipofuscin. Lipofuscin is a heterogeneous material with a prominent 
yellow-brown pigment and is commonly known as the ‘age pigment’ as it typically 
accumulates throughout the body with age (Feeney, 1978). In the RPE, lipofuscin 
originates from the incomplete lysosomal digestion of phagocytosed photoreceptor 
outer segments. The resulting oxidised lipid residues start to accumulate in the basal 
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side of the RPE cells and can fill the entire cytoplasm by the 5th decade (Binder et 
al., 2007). As the cytoplasm becomes engorged, oxidative stress within the cell 
begins to appear (Bonilha, 2008). The visible light spectrum and the local oxygen-
rich environment are able to generate reactive oxygen intermediates from these 
oxidized residues which can further inactivate the lysosomal and antioxidant 
enzymes within the cytoplasm (Wassell et al., 1999). This magnifies intracellular 
oxidative stress, forming a chronic feedback loop. The main lipofuscin flurophore 
A2E, can have phototoxic and detergent properties on membrane bound organelles 
and has been shown to induce apoptosis within cultured cells (Wassell et al., 1999) 
With increasing age, Bruch’s membrane thickens, calcifies and demonstrates 
an accumulation of oxidised waste products derived from RPE metabolism. Overall, 
these age-related changes have a negative effect on its’ structural integrity and ability 
to facilitate fluid movement (Booij et al., 2010). In young eyes, the three fibrous 
layers (inner collagenous, elastin and outer collagenous) allow for maximum 
diffusion of nutrients and oxygen. As we reach our late thirties, there is an 
accumulation of debris and collagen crosslinking within Bruch’s membrane which 
causes a reduction in effective pore size and a decrease in flow through the layers 
(Marshall et al., 1998). Elastolysis is a normal physiological process seen in ageing 
(Vrhovski & Weiss, 1998), and a 1 % decrease in elasticity of Bruch’s membrane 
every year from the age of 21 has been demonstrated (Ugarte et al., 2006). The 
decrease in flexibility of the membrane can lead to brittleness and cracks (Bonilha, 
2008). In later life, an increasing presence of hydrophobic lipids, arranged in the 
inner collagenous layer, known as ‘the lipid wall’, can severely reduce the water 
transport capacity through Bruch’s membrane. This triggers further deterioration in 
transport capacity, inducing the deposition of basal laminar deposits below the RPE 
and along Bruch’s membrane (Guymer et al., 1998). 
Consistent with a thickening of Bruch’s membrane with age (2 µm to 4.7 µm), 
there is a reduction in capillary lumen diameter from 9.8 µm to 6.5 µm (Ramrattan et 
al., 1994). There is also a 45 % decrease in the density of the choriocapillaris from 
the first decade of life to the tenth. The changes in this vasculature structure are 
thought to be caused by the impeded movement of trophic factors secreted by the 
RPE (Bonilha, 2008), and atrophy of the choriocapillaris (and the reduced blood 
supply) further disrupts the balance of growth factors secreted by the RPE (Bhutto & 
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Lutty, 2012). The age-related changes in Bruch’s membrane also involve a disruption 
to extracellular matrix turnover. This can include an up-regulation in the expression 
and activation of extracellular matrix mellatoproteinases (MMPs), which have been 
shown to stimulate pathological angiogenesis (Hollburn et al., 2007). The 
degradation products of elastolysis alone have been shown to cause vasodilation, 
cellular migration and inflammation, especially in tissue that has already been 
damaged (Vrhovski & Weiss, 1998).  
Conversely, changes to the corresponding enzyme inhibitors, especially the 
tissue inhibitor of metalloproteinase-3 (TIMP-3), may also have important clinical 
implications. TIMP-3 is unique among TIMPs as it is a normal component of the 
Bruch’s membrane matrix structure (Fariss et al., 1997) and an accumulation of 
TIMP-3 within Bruch’s membrane is considered a normal aging process (Kamei & 
Hollyfield, 1999). TIMP-3 can also bind to, and be stimulated by the extracellular 
glycoprotein, fibulin-3, which is another important component of Bruch’s membrane. 
The regulatory roles of these molecules are not yet clear (Klenotic et al., 2004; 
Zhang & Marmorstein, 2010). However, the influence of these structural changes is 
highlighted when considering hereditary conditions when premature ageing of 
Bruch’s membrane causes a similar presentation to AMD, but at a younger age, as 
seen in Sorsby fundus dystrophy (TIMP-3 mutation) and Malattia Leventinese, also 
known as Doyne honeycomb retinal dystrophy (EFEMP1/fibulin-3 mutation) (Nita et 
al., 2014; Sivaprasad et al., 2008). Age-related deterioration of the RPE, Bruch’s 
membrane and the choriocapillaris can be a potential trigger for the onset of disease 
processes, such as AMD.   
2.3 AGE-RELATED MACULAR DEGENERATION 
The progression to advanced AMD pathology is a complex series of events that 
involve signiﬁcant changes in Ruysch’s complex. Two types of advanced AMD have 
been identified: dry and wet (de Jong, 2006). Dry AMD (the advanced form is also 
called geographic atrophy) is characterized by a confluent area of photoreceptor, 
RPE cell and choriocapillaris atrophies, which can lead to degeneration of the 
overlying neurosensory retina. Neovascular or wet AMD is characterised by 
choroidal neovascularisation that spreads apically through breaks in Bruch’s 
membrane, the RPE monolayer, and into the sub- and intra-retinal spaces. This 
pathologic vascularisation starts as capillary-like vessels that are often 
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underdeveloped, leaky and can cause haemorrhagic detachments of the RPE and 
neurosensory retina that leads to disciform scarring (de Jong, 2006). 
The aetiology of AMD is multi-factorial – including physiological ageing, 
genetic, inﬂammatory, and environmental factors. A key feature of early AMD 
pathology is the appearance of drusen. It has been suggested that drusen is the 
accumulation of lipofuscin and extracellular deposits beneath the RPE and within 
Bruch’s membrane, the presence of which can further exacerbate the formation of 
drusen (Marshall et al., 1998). Although drusen can be present without a progression 
to disease, there is higher risk for progression to an advanced AMD pathology once 
its presence can be detected by the naked eye, especially once areas of soft indistinct 
drusen appear (de Jong, 2006). More recently, reticular pseudodrusen has also been 
recognised as an important predictor of AMD progression. These are focal deposits 
within the subretinal space and contain similar molecules to those observed in sub-
RPE drusen. They are associated with atrophy of the outer retina, thinning of the 
choroid in the macular region, and geographic atrophy progression (Curcio et al., 
2013; Curcio et al., 2005). 
Different potential therapies for AMD treatment have been trialled including: 
dietary supplementation with vitamins and antioxidants; laser treatment with or 
without photosensitizing dye; submacular membranectomy with or without RPE 
transplantation or translocation; macular translocation surgery; radiotherapy; gene 
therapy; and pharmacological treatment (e.g. angiostatic steroid and anti-VEGF 
therapy) (Binder et al., 2007). Currently, anti-VEGF therapies are the most promising 
treatment and can improve and/or stabilize neovascular AMD when used on a 
monthly schedule (Lanzetta et al., 2013). However, a much larger proportion of 
AMD sufferers develop dry AMD for which no established treatment is available. 
Theoretically, restoration of visual function with anti-VEGF treatment relies on 
neovascularisation being the only pathology, specifically, the RPE cells and Bruch’s 
membrane are still functioning and photoreceptors have not begun to degenerate 
(Thumann & Walter, 2008). As it is highly unlikely neovascularisation is the only 
pathology in patients who require anti-vascular therapies, a surgical intervention that 
replaces the damaged RPE cells, Bruch’s membrane and choriocapillaris, thereby 
restoring the outer blood-retinal barrier, may still be the best curative approach for 
both types of advanced AMD. 
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2.4 RPE TRANSPLANTATION 
Seminal experiments using Royal College of Surgeons (RCS) rats (Li & 
Turner, 1988) demonstrated that the inherited retinal degeneration that manifests in 
this animal model (a mutation prevents the RPE from phagocytosing shed 
photoreceptor outer segments) could be prevented by RPE cell transplantation. This 
form of retinal degeneration is seen in humans as a subtype of retinitis pigmentosa 
(Gal et al., 2000). After the first human submacular surgery to remove diseased 
tissue was performed by de Juan and Machemer (1988), surgical intervention for 
human AMD patients began to focus on the same transplantation principle (i. e., 
replace diseased RPE cells with healthy cells before photoreceptor degeneration 
could progress or even occur). 
Extending upon the investigations of de Juan and Machemer (1998), Peyman et 
al., (1991) performed the ﬁrst RPE transplantations in humans, whereby submacular 
scar excisions in two patients were followed by translocation of an autologous RPE 
pedicle ﬂap or transplantation of an allogeneic adult RPE–Bruch’s membrane-
choroidal tissue explant. Both techniques involved significant surgical skill and 
surgical trauma. Unfortunately in this study, surgical trauma caused the ultimate 
failure for the pedicle flap technique, and allogeneic rejection caused failure of the 
explant technique. This attempt was followed by trials of transplantation of foetal 
human RPE patches (Algvere et al., 1994, 1999) after the removal of a subretinal 
membrane commonly identified as choroidal neovascular membranes (CNVM). 
These patients were able to ﬁxate over the area of the RPE graft initially, but cystoid 
macular oedema ensued and eventually the grafts were encapsulated by ﬁbrotic scars, 
which might be a result of immune rejection as none of the patients were 
immunologically suppressed.  
The iris pigment epithelium (IPE) has been proposed as an autologous source 
of pigmented cells. IPE share the same embryonic origin as the RPE and possess 
similar morphological features such as pigmentation and tight junctions (Thumann et 
al., 1999, 2000). A simple biopsy can harvest sufficient cells for transplantation and 
they have been shown to acquire RPE-like morphology when injected into the 
subretinal space of rabbits and RCS rats (Thumann et al., 1999). However, 
transplantation of suspensions of autologous IPE cells has not resulted in a prolonged 
improvement of vision in AMD patients (Thumann et al., 2000). It was suggested 
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that this failure may have occurred because the transplanted IPE cells did not fully 
differentiate into cells that had the morphological and physiological properties of 
RPE cells in situ. Transplanted suspensions of autologous RPE cells have been 
reported to confer some improvement in eyes with wet type AMD after removal of 
CNVM (Binder et al., 2002). These eyes had signiﬁcantly better reading acuity than 
the controls where only CNVM was removed. However, obtaining sufﬁcient 
numbers of RPE cells was sometimes difﬁcult, and in some patients the aspirated 
RPE cells were not transplanted because of insufﬁcient numbers or haemorrhage. 
In most of these studies, suspensions of isolated cells were injected into the 
subretinal space. Pivotal experiments by Tezel and Del Priore (1997) showed that 
RPE cells are anchorage-dependent and must re-attach to a substrate to prevent the 
initiation of apoptosis. The development of an RPE monolayer with proper cell 
polarity and function can only occur once re-attachment is successful. The significant 
structural and functional changes that occur within Bruch’s membrane with age can 
have a profound and detrimental effect on RPE attachment, monolayer establishment 
and transplant survival (Sugino et al., 2011; Tezel et al., 1999; Tezel & Del Priore, 
1999). Crafoord et al., (2002) confirmed this in their studies, finding that the 
photoreceptor cells survived well when transplanted IPE cells established into a 
monolayer, but the photoreceptors did not survive when the transplanted cells 
clustered into a mound-like shape. Moreover, RPE cells in suspension may not settle 
in the subretinal space but instead migrate into the vitreous cavity, whereby they 
become ﬁbroblastic in nature and produce a contractile extracellular matrix, which 
can eventually contract in the form of epiretinal membrane or proliferative 
vitreoretinopathy (Hiscott & Sheridan, 1998; Pastor et al., 2002). These may result in 
macular pucker and retinal detachment, which will have a detrimental effect on the 
visual outcome. 
Two surgical techniques to reconstitute submacular RPE (macular translocation 
and autologous RPE–Bruch’s membrane–choroid transplantation) have been refined 
and used to restore foveal photoreceptor contact to an area of relatively healthy, 
albeit ageing RPE. The techniques have met with some success (patients have 
experienced a gain in visual acuity after surgery) and serve as a proof of the principle 
that some photoreceptor function can be restored in AMD (Van Zeeburg et al., 2012; 
Chen et al., 2009). Despite these encouraging results, the age of the patient (and their 
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cells) remains as an inhibiting factor for a reliable and reproducible treatment. The 
pre-operative viability of the photoreceptors and the state of disease advancement in 
the RPE cells has been previously suggested as the best predication for the 
progression of natural history of AMD irrespective of which therapy may be used (da 
Cruz et al., 2007). Therefore the precise timing of intervention is imperative. 
Essentially a therapy for AMD needs to be performed at earlier stages of 
degeneration so there is a better chance of preservation and restoration of function 
without untoward effects on the patient (Gouras, 1998). It is considered that a pre-
made patch, which has a functioning monolayer of RPE cells and a Bruch’s 
membrane substitute, will simplify the surgical technique and thus potentially, 
reduce complication rate. The identification of new sources of human RPE cells and 
exploring the option of custom-creating a healthy Bruch's membrane are two areas 
receiving increased attention. 
2.5 PLURIPOTENT STEM CELLS AND THE RPE 
A new field of cell biology emerged in 2007 when Shinya Yamanaka 
announced that human induced pluripotent stem cells (hiPSCs) had been derived 
from adult human fibroblasts (Takahashi et al., 2007). This seminal publication 
followed the isolation of the original pluripotent cells, human embryonic stem cells 
(hESCs), by James Thomson in 1998 (Thomson et al., 1998). As hiPSCs do not carry 
the ethical and moral oppositions that surround the use of human embryos, 
Yamanaka’s discovery, confirmed concurrently by Thomson’s group (Yu et al., 
2007), was even more exciting. The existence of human pluripotent stem cells, either 
of an embryonic or induced (adult) origin, swiftly and permanently changed the 
future direction of biomedical research. A substantial amount of research has been 
conducted exploring the potential of pluripotent stem cells for modeling and 
treatment of human disease (Tabar & Studer, 2014).  
Despite the initial widespread enthusiasm for this stem cell technology its 
appeal is somewhat reduced when the sophisticated biology of pluripotent stem cells 
and the complex technical issues related to the use of the cells is considered (Hayden, 
2011). For example, a problem associated with the use of embryonic stem cells is the 
allogeneic source. As a consequence, it is highly likely that immunosuppression will 
be required for patients receiving differentiated hESCs as cell therapy. Traditionally, 
immunosuppressant treatment requires lifelong administration and significant 
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systemic health burdens. This required treatment is compounded by the continuing 
issue of teratoma formation by incomplete differentiation of embryonic stem cells 
(Wang et al., 2010). It may be possible to interrupt specific pathways of T-cell 
activation for an interim period of time after the implantation of an allogeneic hESC-
derived graft, however these methods are yet to be optimised and evaluated in 
humans (Pearl et al., 2011; Rong et al., 2014). Reprogramming, the generation of 
hiPSCs from somatic cells, is a highly inconsistent process, and the best (high yield) 
protocol is yet to be completely defined (Borooah et al., 2013). Specific impediments 
to the translation of therapeutic stem cell technology include variation in 
differentiation potential between donor cell types (i.e. from a blood sample, skin 
biopsy), harnessing the signalling pathways that influence directed differentiation 
(converting the hESC or hiPSC to the desired cell fate) to adult-like physiology, 
optimising conditions for three-dimensional cytoarchitecture,  a high incidence of 
mutational changes in differentiated cells, and the non-erasure of epigenetic memory 
of the donor cell source (Melville et al., 2013; Tabar & Studer, 2014). The utility of 
human pluripotent stem cells lies with their potential to differentiate into virtually 
any cell type. Protocols for generating differentiated cells from pluripotent stem cells 
follow two distinct paths, each with specific benefits and considerations. The first 
protocol type involves adherent cultures with growth factors being included and 
excluded from the culture medium at different time points; the second protocol 
utilizes suspension cultures able to generate embryoid bodies, and subsequent 
adherent culture time. Both protocol types involve selective isolation and manual 
dissection of the cells of choice, and extended culture time frames (Rowland et al., 
2012). The distinctive pigmentation of RPE cells allows, with relative ease, the 
identification, dissection, culture and expansion of this cell type (Gamm et al., 2013). 
Consequently, RPE cells generated from pluripotent stem cells are being pursued 
with fervent interest. 
The potential impact of pluripotent stem cell-derived RPE cells can be seen in 
the fields of regenerative medicine, pathology research and drug development 
studies. Currently, both hESC-RPE and hiPSC-RPE are being evaluated for use in 
the treatment of AMD. Trials are currently underway, (Phase I/II Clinical Trial; 
#NCT01344993) evaluating the safety and tolerability of a subretinal injection of 
hESC-RPE in patients with advanced dry AMD. After 4 months, ophthalmic 
examination indicated that the injection was well tolerated with cells attaching and 
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persisting throughout the trial period (Schwartz et al., 2012). Furthermore, the 
medium term (22 months) safety outcome was encouraging, with no development of 
uncontrolled proliferation, rejection or serious systemic adverse reaction (Schwartz 
et al., 2014). It is yet to be seen if an injection of hESC-RPE cells into the subretinal 
space will provide any functional improvement in humans. 
The therapeutic value of monolayers of hESC-RPE cells grown on thin 
submicron membranes made from Parylene C, a synthetic polymer that has been 
used as a barrier coating on circuit boards and implantable medical devices, is 
currently being investigated in a collaborative program between the University of 
Southern California and the Doheny Eye Institute (Diniz et al., 2013; Ribeiro et al., 
2013; Hu et al., 2012; Lu et al., 2012;). In particular, the feasibility of implanting this 
biomaterial substratum into the subretinal space of the RCS rat has been investigated 
(Hu et al., 2012) and the long-term survival of the implanted cells (up to 8 months) 
has been observed (Ribeiro et al., 2013). The group is yet to report a functional 
improvement in RCS rat visual function as a result of this implant, and how these 
results might translate into a human AMD patient.  
Masayo Takahashi from RIKEN Center for Developmental Biology in Kobe, 
Japan is currently undertaking the first clinical study using hiPSCs in human patients 
(RIKEN Press Release, July 30, 2013). It is intended to establish hiPSC-RPE from 
six patients who have wet AMD, utilizing a collagen type I gel to create cell sheet 
monolayers (Kamao et al., 2014). The hiPSC-RPE cell sheets will be used as a graft 
and transplanted into the affected site of a single eye for each patient (after the 
CNVM is stabilised with a course of anti-VEGF drug, Ranibizumab, injections). The 
group have reported successful surgery for the first patient (Cyranoski, 2014). 
Functional integration and adverse reactions will be monitored over a three-year 
period. The significance of this clinical study, to researchers and AMD patients alike, 
cannot be overstated.  The outcomes of this study will provide insight into the 
effectiveness of transplanting a sheet of RPE without reconstructing Bruch’s 
membrane in treating advanced AMD. More broadly speaking, this study and the 
corresponding regulatory changes that have been made at government level will 
influence every aspect of hiPSC technology moving forward and is being closely 
watched by the scientific community (Reardon & Cyranoski, 2014). 
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2.6 BIOMATERIALS FOR RPE TRANSPLANTATION 
Any biomaterial considered as a potential replacement for Bruch’s membrane 
must fulfil a range of specific structural and functional criteria. For example, it will 
need to be supportive of cell attachment and differentiation, structurally thin yet 
surgically robust enough to be introduced into the subretinal space. The substitute 
will need to be biocompatible and immunologically inert with a controllable rate of 
biodegradation (Wang et al., 2006). Permeability of the biomaterial and a water 
transport capacity comparable to a young Bruch’s membrane will be vital to prevent 
pooling at the RPE-substrate interface (da Cruz et al., 2007). Biomaterials that could 
be used as a potential substitute for Bruch’s membrane and their capacity to support 
cell attachment and correct cell phenotype development have been explored and 
extensively reviewed a number of times (Binder, 2011; Hynes & Lavik, 2010). Some 
substrates (i.e. films and membranes) could support the delivery of the cell 
monolayer during surgery, whereas other substrates would need to be removed prior 
to monolayer transplantation (thermoresponsive polymers and gelatin). So far, there 
has not been a substrate that has all the necessary requirements.  
An important consideration when selecting a biomaterial for this area is 
whether the transplanted RPE would eventually need to re-attach and/or interact with 
the aged Bruch’s membrane. For example, will the biomaterial degrade quickly, 
exposing the transplanted cells to an aged Bruch’s membrane? If the biomaterial will 
not expose the transplanted RPE cells to the aged Bruch’s membrane, is it an 
appropriate addition to the subretinal environment? The thickness and permeability 
of biomaterials that have been tested for RPE cell attachment (and differentiation in 
some studies) to this point are often incompatible for implantation into the subretinal 
space. 
Out of the multitude of studies that have evaluated potential substitutes for 
Bruch’s membrane, only four have used differentiated RPE cultures and implanted 
them into animal models. The materials that have been used include collagen type I 
in cross-linked and uncross-linked forms (Bhatt et al., 1994), anterior lens capsule 
(Nicolini et al., 2000), the synthetic polymer called parylene C (Diniz et al., 2013) 
and commercial polyester membranes (Stanzel et al., 2014). Only one group used an 
animal cell source (Nicolini et al., 2000) that matched the animal host, the other 
groups used human cell sources (embryonic-derived RPE, fetal RPE and adult RPE 
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stem cells). The animal models used to test the safety, tolerability and survival of the 
implants included rabbits (Bhatt et al., 1994; Stanzel et al., 2014), pigs (Nicolini et 
al., 2000) and immuno-compromised nude rats (Diniz et al., 2013). 
 Bhatt et al (1994), showed great theory when designing their study. They 
hypothesised it would be better to implant a monolayer of RPE cells, they also 
removed the host RPE cells before implanting the RPE-biomaterial complex, and 
they used a material with a biological origin which would most likely degrade 
without potentially harmful by-products. They found the un-crosslinked collagen 
type I substratum was flexible and conformed to the surface of the host’s intact 
Bruch’s membrane. Little evidence of the uncross-linked collagen substrate was seen 
6 weeks after surgery, however the retinal layers above the implant (identified by the 
pigmented cells that had been implanted into the unpigmented rabbit model) 
appeared normal. In contrast, the cross-linked collagen substratum did not degrade 
over the post-surgery monitoring time period, and there was obvious damage to the 
retinal layers above the implant. The authors suggested that by crosslinking the 
collagen, it may have condensed the structure and reduced the diffusion capability 
between the choroid and the photoreceptors.  Similar to the uncross-linked collagen 
substrata, anterior lens capsule (ALC) was also well tolerated within the subretinal 
space (Nicolini et al., 2000). Unfortunately due to the elastic membrane-like nature 
of the ALC, it curled upon implantation in the subretinal space. The donor RPE cells 
were still attached to the ALC and were present at 2 weeks post-surgery however as 
they were curled up inside the ALC they were not presented to the photoreceptors. 
The authors recommended that the ALC would need to be structurally modified 
before it could be used as a viable Bruch’s membrane substitute.  
The most recent investigations have used synthetic materials, parylene C 
(Diniz et al., 2013) and polyester membranes (Stanzel et al., 2014). Both studies 
resulted in damage to the overlying retinal layers (presumably caused by a disruption 
to photoreceptor-choroid nutrient and waste transfer), however they were able to 
show survival of the implanted RPE cells on the synthetic substrata in the subretinal 
space. Diniz et al (2013) showed a monolayer of RPE cells survived better than a 
suspension of RPE cells injected into the subretinal space. They also confirmed 
differentiation of their embryonically-derived RPE cells by evaluating them in an 
immune-compromised nude rat model and no teratoma formation was observed. 
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Stanzel et al (2014) were the first to implant human adult RPE stem cells into an 
animal model, and the cells survived and kept their differentiated morphology and 
survived in the subretinal space over the monitoring period. Further work by this 
group is focussed on using a more porous substratum that will support native (more 
appropriate) nutrient and waste exchange. 
2.7 SILK FIBROIN 
There is much interest in using silk as a biomaterial (Gil et al., 2013; Harkin et 
al., 2011; Wenk et al., 2011; Murphy & Kaplan, 2009; Hakimi et al., 2007; Vepari & 
Kaplan, 2007; Wang et al., 2006; Altman et al., 2003;). Silk proteins belong to the 
family of ﬁbrous proteins, which also includes collagens, elastins, and myosins, and 
already have a long history of use as a surgical suture material. There is an enormous 
range of silks, which are produced predominantly by the larvae of insects from the 
order Lepidoptera (i. e., moths and butterﬂies) and by spiders (Araneae) (Chirila et 
al., 2008). 
Silkworm silk is a high molecular-weight polypeptide composite made up of 
two fibroin proteins; a light chain (25 kDa) and a heavy chain (325 kDa), joined 
together in a 1:1 ratio with a single disulphide bond. A sericin coat, made up of glue-
like proteins, encases these core fibers (10-25 µm diameter) holding them together 
and forming the cocoon case (Chirila et al., 2008; Vepari & Kaplan, 2007; Altman et 
al., 2003). Historically there have been incidences of adverse tissue reaction linked to 
the sericin coat when silkworm silk is used in raw form, however, new protocols for 
the purification of fibroin, have eliminated this contamination and confirmed 
biocompatibility in vitro and in vivo (Meinel et al., 2005; Altman et al., 2003).  
Due to its versatility and remarkable mechanical properties, regenerated 
aqueous solutions of Bombyx mori silk fibroin have been used to form a variety of 
biomaterials including films, sponges and electrospun mats (Chirila et al., 2008; 
Vepari & Kaplan, 2007). The primary structure of fibroin has significant 
homogeneity (highly repetitive amino acid sequence) and its secondary structure is 
composed of highly organised β-sheets. This arrangement is the basis of the 
material’s high tensile strength (Wang et al., 2006; Altman et al., 2003). The 
structural stabilisation of biomaterials made using regenerated fibroin solution can be 
controlled by inducing β-sheet crystallinity using a temperature-controlled water 
 40 Literature Review  
vapour annealing process (Hu et al., 2011). Fibroin is degradable, biocompatible and 
chemically modifiable (Vepari & Kaplan, 2007; Meinel et al., 2005). 
2.8 SILK FIBROIN AND RPE 
Membranes fabricated from silk ﬁbroin, have been assessed and evaluated as a 
template for growing monolayers of RPE cells in vitro, and shows potential as a 
Bruch’s membrane substitute. In a pilot study by our group (Kwan et al., 2010) 
fibroin was investigated as a substratum for RPE cultures both alone or coated with a 
selection of ECM proteins, in the presence or absence of serum. Using a human RPE 
cell line, ARPE-19 cells were seeded onto tissue culture plastic (TCP), fibroin 
membrane alone, or fibroin membranes coated with laminin, vitronectin, ﬁbronectin, 
a laminin–vitronectin–ﬁbronectin combination (LVF), or collagen type IV. Samples 
were cultured in media containing fetal bovine serum (FBS) for 72 hours, then ﬁxed 
and stained with nuclear stain Hoechst, after which cells attached were counted. 
Experiments were repeated with serum-starved ARPE-19 cells, which were seeded 
on to the different substrata, and cultured under serum-free conditions for 24 hours. 
The results showed that ARPE-19 cell growth on the fibroin membrane was not 
significantly different (p < 0.05) to that observed using TCP and FBS-containing 
culture conditions. The ARPE-19 cell count on the fibroin membrane alone in serum-
free culture conditions was 50% of that on standard TCP in FBS (p = 0.01). 
However, the cell counts on fibroin membranes coated with ECM proteins surpassed 
unmodiﬁed fibroin membrane alone (vitronectin > collagen IV > ﬁbronectin > LVF > 
laminin). Furthermore, cell attachment on fibroin membranes coated with vitronectin 
or collagen IV in serum-free conditions was found to be comparable with that seen in 
medium containing FBS on TCP. 
Following this preliminary study the attachment, growth and morphology of 
human RPE cells grown on membranes prepared from fibroin were assessed 
(Shadforth et al., 2012). Fibroin membranes measuring only a few microns in 
thickness that had been rendered porous by casting fibroin in the presence of low 
concentrations of poly(ethylene oxide) (PEO) were utilised. In considering the 
importance of nutrient/waste exchange in vivo, it was considered at the time to be the 
best representation of a prosthetic Bruch’s membrane based on fibroin. Permeability 
of the membranes was evaluated using a horizontal diffusion cell and three model 
molecules (with molecular weights between 0.4 and 70 kDa) and were found to be 4-
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fold more permeable than native Bruch’s membrane. We conducted a morphological 
assessment of long-term ARPE-19 cultures (2 months) which resulted in the partial 
formation of tight junctional complexes (expected of ARPE-19 cells, assessed using 
ZO-1 immunocytochemistry) and extension of microvilli from the apical surface 
(visualised by electron microscopy). The feasibility of establishing primary cultures 
of adult human RPE cells on fibroin compared with conventional TCP was also 
evaluated. Primary adult RPE cultures established at a slower rate on fibroin, when 
compared to TCP, nevertheless they formed morphologically correct cultures and 
tight junctional complexes. Considering these encouraging results, fibroin 
membranes warrant further investigation as a Bruch’s membrane substitute. 
Strikingly, when biomaterial substrates are being tested and evaluated as a 
Bruch’s membrane substitute, the adoption of correct cell morphology is most often 
the only “test” done on RPE cell cultures. Cells may have the correct morphology; 
however this does not confirm their functionality. A complete functional assessment 
of the RPE monolayer grown on fibroin membranes is needed to confirm it is 
capable of performing the vital functions required of a fully functional in vivo 
monolayer. Several groups have developed and performed functional tests on human 
adult RPE, human fetal RPE and RPE cells derived pluripotent stem cells (embryonic 
or induced adult origin) to confirm they have acquired RPE functions (Stanzel et al., 
2014; Blenkinsop et al., 2013; Salero et al., 2012; Kokkinaki et al., 2011; Sonoda et 
al., 2009; Maminishkis et al., 2006). Considering the functional requirements of an in 
vivo RPE monolayer, in vitro testing of RPE cultures grown on fibroin membranes 
could include testing barrier function formation, visualising the polarisation of 
metabolic proteins, quantifying polarised growth factor secretion, and testing the 
selective phagocytic ability of the transmembrane integrin, αVβ5. 
A major consideration in developing any biomaterial substitute for Bruch’s 
membrane is to determine the necessity of including elastin in the formulation. As 
described previously, the native Bruch’s membrane contains a central core of elastin. 
It has been reported that the elasticity of this membrane decreases with age leading to 
the appearance of breaks (Ugarte et al., 2006). As a consequence, there is a strong 
rationale to determine if the properties of a potential Bruch’s membrane substitute 
can be improved with the incorporation of elastin. Elasticity is typically imparted to 
tissue by a process of elastic fiber assembly (Kozel et al., 2004). The elastic fiber 
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assembly, arranges elastin (secreted from cells as tropoelastin and converted by lysyl 
oxidase) with microfibrils to form elastin fibers. RPE cells have been shown to 
produce both microfibrils and lysyl oxidase (Wachi et al., 2005), so by incorporating 
the elastin precursor tropoelastin in the delivery substrate with new RPE cells, it may 
encourage a permanent Bruch’s membrane template to be formed in vivo. Combined 
solutions of fibroin and recombinant human tropoelastin have been studied 
previously (Hu et al., 2011; Hu et al., 2010) and the resultant blended biomaterial 
membrane exhibited improved strength and elasticity, and was shown to support the 
attachment and proliferation of human mesenchymal stem cells.  
2.9 INCORPORATING A VASCULAR COMPONENT 
Creating a fully functional in vitro RPE-Bruch’s membrane complex will be an 
important advance in developing an appropriate replacement for the diseased RPE 
and Bruch’s membrane seen with age in vivo. However it is still missing an 
important subretinal structure, the choriocapillaris. It has been suggested that a layer 
of vascular endothelial cells should be added to the basal side of an RPE-Bruch’s 
membrane transplant, creating an “ultimate bioprosthesis” (Binder et al., 2007). The 
vascular endothelial cells of this tri-layered complex may improve anchorage within 
the host vasculature upon transplantation and assist in re-establishing blood supply.  
A simple trilayer model of this complex was established and described by 
Hamilton et al (2007). This in vitro model used ARPE-19 cells, denuded human 
amniotic membrane and human umbilical vein endothelial cells (HUVECs) to 
replicate the three in vivo layers. Results from this group show their trilayer culture is 
a promising model; however, the use of amnion and HUVECs pose several 
problems. Amnion, like any allogenically derived material, could be a source of 
infection and rejection to the eventual patient. More importantly, the thickness of 
amniotic membrane at 60-100 µm is not an appropriate substitute for the native 
Bruch’s membrane (3 µm). Human amniotic membrane has also been found to be a 
source of growth factors (Shao et al., 2004) which could potentially alter the critical 
balance of growth factors required for normal retinal structure and function. 
HUVECs, derived from the vein of the umbilical cord, are a macrovascular cell type 
and may well lack the specific features required to replicate the distinct and small 
capillary vessels of the choriocapillaris. A microvascular endothelial cell line or 
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specifically choroidal-derived endothelial cells would be a better representation of 
the in vivo environment.  
Choroidal vascular endothelial cells and RPE cells have been grown together in 
culture and the interaction was described by Sakamoto et al (1995). This group 
highlighted the heterogeneity and organ-specificity of vascular endothelial cells, and 
showed vessel formation by choroidal-derived vascular endothelial cells in vitro is 
modulated by RPE cells. Both cell types were isolated from bovine tissue. The 
choroidal-derived vascular endothelial cells were seeded within a collagen type I gel 
and the RPE cells were seeded on the surface of the polymerised gel. The presence of 
the RPE cells promoted angiogenesis of the vascular endothelial cells within the gel. 
Unfortunately the culture setup did not use a Bruch’s membrane substitute, and there 
was no physical barrier (other than the collagen gel) between the two cell types. 
Therefore it was not truly representative of the subretinal architecture. 
Another RPE-choroidal endothelial cell co-culture model has been established 
and was described by Fan et al (2002). They put special emphasis on using choroidal 
vascular endothelial cells derived from human tissue, and co-culturing the cell types 
with a definite interface between them. Fan and colleagues were also able to show 
functional interactions in their co-culture model. Unfortunately their co-culture setup 
allows these interactions to be studied primarily as an in vitro model only, with no 
ability to use it in an in vivo application. The co-cultures were assembled by placing 
cultures of mature ARPE-19 cells grown on Transwell
®
 filters over human primary 
choroidal-derived vascular endothelial cells sandwiched within a collagen gel coating 
the TCP surface below. There was a functional interface between the two cell types 
however the complex was essentially two parts grown closely together. They did not 
attempt to recreate the Bruch’s membrane-choriocapillaris architecture and it could 
not be considered as a single unit complex that could stand alone. 
2.10 SUMMARY 
There is a need to identify the ideal template for the growth of RPE cells with the 
aim of creating potential RPE transplantable constructs, as current clinical therapies 
are inadequate for treating the different presentations of AMD. Although there have 
been some advances in the development of potential templates for RPE cell growth 
and maintenance, it remains unclear as to what represents the best substratum (e.g. 
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material), the most suitable vascular components (e.g. underlying vascular scaffold), 
the best microenvironment (e.g. combination of growth factors), the ideal cell type, 
and the most appropriate timing of the surgery. Solving such problems and 
overcoming the current limitations of available biomaterials for RPE substrates will 
certainly make a positive contribution to those whose lives are impacted upon by 
AMD.  
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A Bruch’s membrane substitute fabricated from silk fibroin supports the 
function of retinal pigment epithelial cells in vitro 
3.1 ABSTRACT 
Silk fibroin provides a promising biomaterial for ocular tissue reconstruction, 
including the damaged outer blood-retinal barrier of patients with AMD. The aim of 
the present study was to evaluate the function of RPE cells grown on fibroin 
membranes manufactured to a thickness similar to that of Bruch’s membrane (3 µm). 
Confluent cultures of RPE cells (ARPE-19) were established on fibroin membranes 
and maintained under conditions designed to promote maturation over 4 months. 
Control cultures were grown on porous polyester cell culture well inserts 
(Transwell
®
). Cultures established on either material developed a cobblestoned 
morphology with partial pigmentation within 12 weeks. Negligible change in TER 
was observed for cultures grown on either material, however this result is in keeping 
with prior studies of ARPE-19 cell function. Immunocytochemistry at 16 weeks 
revealed a similar distribution pattern between cultures for F-actin, ZO-1, ezrin, 
cytokeratin pair 8/18, RPE-65 and Na
+
/K
+
-ATPase. Electron microscopy revealed 
that cultures grown on fibroin displayed a rounder apical surface with a more dense 
distribution of microvilli-like projections. Cultures grown on either material avidly 
ingested fluorescent microspheres coated with both vitronectin and bovine serum 
albumin (BSA), but not controls coated with BSA alone. VEGF and PEDF were 
routinely detected in the conditioned medium collected from above and below the 
two membrane types. Levels of PEDF were significantly higher than for VEGF on 
both membranes and a trend was observed towards larger amounts of PEDF in apical 
compartments. These findings demonstrated that RPE cell functions on fibroin 
membranes are equivalent to those observed for standard test materials (polyester 
membranes). As such, these studies support advancement to studies of RPE cell 
implantation on fibroin membranes in a pre-clinical model. 
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3.2 INTRODUCTION 
Bruch’s membrane is an important extracellular matrix structure within the 
outer retina. The structure and composition of this membrane allows it to act as a 
semi-permeable sieve between the RPE and the fenestrated capillaries of the 
choriocapillaris, collectively termed Ruysch’s complex (de Jong, 2006). The barrier 
and permeability characteristics of Bruch’s membrane are vital to sensory retina 
function and the maintenance of homeostasis within the subretinal space more 
generally (Booij et al., 2010). In patients with AMD, however, Bruch’s membrane 
becomes thickened, brittle, cracked and filled with oxidised waste products. These 
changes promote alterations in the structural integrity of the choriocapillaris, a 
breakdown in the outer blood-retinal barrier, and loss of RPE cells, which ultimately 
leads to vision impairment through an accompanying loss of photoreceptors (Marmor 
& Wolfsenberger, 1998). 
The transplantation of RPE cells as a therapeutic treatment for retinal 
degeneration has been extensively investigated in humans, however, the 
transplantation of RPE cells without addressing the structural defects in Bruch’s 
membrane has not resulted in favourable therapeutic outcomes (Binder, 2011). The 
concept of implanting a prosthetic Bruch’s membrane in conjunction with healthy 
RPE cells has therefore been proposed (Binder et al., 2007). Thus, instead of simply 
supporting RPE cell attachment and monolayer delivery during surgery, the 
biomaterial scaffold itself would act as an ongoing replacement for Bruch’s 
membrane. This concept takes into consideration the important in vitro studies 
performed by Tezel and Del Priore (1997, 1999) and Tezel et al. (1999) which 
revealed that rejuvenation or replacement of Bruch’s membrane was integral to RPE 
cell attachment, monolayer establishment, and consequently transplant survival.  
A prosthetic Bruch’s membrane should ideally be thin (3-5 µm), permeable, 
strong, flexible, biologically inert, and able to support the functions of RPE cells. 
While, numerous biomaterials have been examined for their potential to act as a 
scaffold to replicate native Bruch’s membrane, few have been tested in vivo, and 
none have managed to incorporate all qualities required of an ideal Bruch’s 
membrane replacement (Binder et al., 2011, 2007; Hynes and Lavik, 2010; Kwan et 
al., 2010).  
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Our group have previously proposed the use of fibroin (isolated from Bombyx 
mori cocoons) membranes as a potential Bruch’s membrane substitute (Harkin et al., 
2011; Shadforth et al., 2012). Fibroin, a fibrous protein produced by spiders, silk 
moths’ larvae and numerous other insects, is responsible for the mechanical 
properties of silk. In our laboratories, fibroin-based membranes have been exploited 
for their potential to support the attachment, growth and differentiation of a range of 
ocular cells (Hogerheyde et al., 2014; Bray et al., 2013; George et al., 2013; Bray et 
al., 2012; Bray et al., 2011; Harkin et al., 2011; Madden et al., 2011; Chirila et al., 
2008).  
The properties that make fibroin attractive as a prosthetic Bruch’s membrane 
include its tensile strength when manufactured as a very thin membrane, 
biocompatibility, permeability, and slow enzymatic degradation. We have previously 
demonstrated that fibroin membranes support the attachment and growth of RPE 
cells, but the functional properties of such cultures have remained unclear. We 
therefore present a detailed analysis of RPE function when grown to maturity on 
fibroin membranes. Our studies have been conducted using the spontaneously 
immortalised human RPE cell line, ARPE-19 (Dunn et al., 1996), that has been 
grown to maturity over 4 months in Miller’s medium (Maminishkis et al., 2006). 
This analysis has been performed in parallel with control cultures grown on 
commercially available porous polyester cell culture membranes (Transwell
®
).  
3.3 MATERIALS AND METHODS 
3.3.1 Production of aqueous solutions of fibroin 
The procedure has been previously described in detail by our group (Chirila et 
al., 2008). Briefly, dried Bombyx mori silkworm cocoons (Tajima Shoji Co. Ltd., 
Yokohama, Japan) were boiled in a solution of sodium carbonate containing 0.85 g 
of salt for each gram of cocoon material. This procedure removed the sericin outer 
coat from the core fibroin protein. The resulting fibrous material was washed and 
dried, and then dissolved (at 60 °C for 4 hours) in a concentrated solution of lithium 
bromide (9.3 M) to obtain a silk concentration of approximately 10 % wt./vol. The 
fibroin solution was subsequently filtered using syringe filters in succession with 
pore size 0.7 µm and 0.2 µm. This step is performed slowly to avoid shearing forces 
that could promote spontaneous gelation. The filtrate was dialyzed against water 
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using a dialysis cassette with a molecular mass cut-off of 3.5 kDa (Slide-A-Lyzer, 
Pierce Biotechnology) using 6 changes of water over 3 days. The resulting fibroin 
solution was filtered again as above and used to produce fibroin membranes. 
3.3.2 Preparation of ultrathin membranes of fibroin 
Fibroin membranes were cast using a custom-made casting table as described 
previously by our group (Bray et al., 2011). The thickness of fibroin membranes was 
measured using an upright micrometer and only areas of membrane 3 µm ± 1 µm 
thick were used. For structural stabilisation of fibroin membranes, β-sheet formation 
was induced by the water-annealing of the membranes in a vacuum oven at -80 kPa 
with ~100 mL water (beaker) for 6 hours at room temperature (25 ºC). The 
permeability of fibroin membranes has been previously examined using a horizontal 
diffusion cell using 3 model molecules (Bray et al., 2011). 
3.3.3 Cell culture of human RPE cell line, ARPE-19 
ARPE-19 cells were routinely cultured using the Miller’s medium formulation 
(Maminishkis et al., 2006); minimum essential medium, alpha modification (MEM-
α, M-4526) supplemented with N1 supplement (N-6530), glutamine-penicillin-
streptomycin (G-1146), non-essential amino acids (M-7145), taurine (T-0625), 
hydrocortisone (H-0396) and triiodo-thyronin (T-5516). All these components were 
purchased from Sigma Aldrich. This medium formulation allows RPE cultures to be 
incubated at 37 °C using a standard level of 5 % CO2 air. Cultures were established 
in the presence of 10 % FBS, and after 24 hours this serum level was decreased to 1 
%. Stock cultures were fed two to three times per week, and passaged routinely using 
Versene (15040-066, Life Technologies) and TrypLE™ (12563-011, Life 
Technologies), between passages number 23 and 28. An independent STR profile 
analysis of our working stocks by the Garvan Institute of Medical Research revealed 
a 100 % match with reference ARPE-19 cell line CRL-2302. 
3.3.4 Using ultrathin fibroin membranes in Teflon® chambers for cell culture 
Discs of ultrathin fibroin membrane (16-mm diameter) were inserted into 
custom-made chambers designed by our group, which are manufactured from 
interlocking Telfon
®
 rings specifically for cell culture use (Fig. 3.1). The combined 
membrane and chamber were sterilised together by immersion in 70 % ethanol for 1 
hour at room temperature, air-dried and washed thoroughly with phosphate buffered 
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solution (PBS) prior to use. The custom-made chamber suspends the fibroin 
membrane (reminiscent of the commercially available Transwell
®
 insert system) 
creating an apical compartment (upper chamber) and a basal compartment (lower 
chamber) on either side of the membrane (Fig. 3.1). This culture setup is required for 
the development of a polarised epithelial culture.  
 
Figure 3.1. Appearance and assembly of fibroin membranes into cell culture 
chamber. (A and C) Appearance of fibroin membrane (16-mm diameter discs) as 
photographed while being held up to light or placed over letter of printed text.  
(B, D and E) Stages of membrane assembly into custom-made cell culture chambers 
consisting of two interlocking Teflon® rings and silicon o-ring. A locking 
mechanism is achieved by manufacturing the upper chamber piece to screw down 
into the base. 
3.3.5 Culture of ARPE-19 on ultrathin fibroin membranes and commercial 
Transwell
®
 permeable membrane inserts 
ARPE-19 cells were seeded onto the apical surface of, ultrathin fibroin 
membranes in chambers, or, polyester membrane in Transwell
®
 inserts (12 mm 
diameter, with 0.4 µm pores, 10 µm thickness. #3460, Corning Inc.) at a density of 
10,000 cells/cm
2
. Both membrane types were pre-coated with a commercial ECM 
blend obtained from human placenta (66 µg/mL, #354237, BD Biosciences) diluted 
in Hank’s buffered salt solution (HBSS). Cultures were incubated at 37 °C and 5 % 
CO2, and were fed twice weekly, with Miller’s medium used in both the apical and 
basal compartments. Cultures were analysed for maturity after four months in 
culture. Cultures were fixed in 3.7 % formaldehyde (for immunocytochemistry) or 3 
% glutaraldehyde (for electron microscopy). Membranes of both types (fibroin and 
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commercial inserts) without cells were used as negative controls for TER studies. 
Measurements of TER were taken over the culture period using the methodology 
outlined by Sonoda et al. (2009) and an epithelial voltohmmeter (EVOM
2
) with the 
STX3 chopstick electrode set (World Precision Instruments). 
3.3.6 Immunocytochemistry 
Cultures were fixed in 3.7 % formaldehyde, blocked in 2 % normal goat serum 
in PBS, permeabilised with 0.5 % Triton X-100 in 100 mM HEPES buffer (pH 7.2), 
and stained with rhodamine phalloidin (R415, Life Technologies) and Hoechst 
nuclear dye (H1399, Life Technologies). Primary monoclonal antibodies to zona 
occludens-1 (ZO-1, 1:100, 33-9100, Clone ZO1-1A12, Life Technologies), ezrin 
(1:100, 35-7300, Clone 3C12, Life Technologies), cytokeratin pair 8/18 (1:10, 
DM189, Clone 5D3, Acris Antibodies), RPE-65 (1:50, ab13826, Clone 
401.8B11.3D9, Abcam), and sodium potassium ATPase (Na
+
/K
+
-ATPase, 1:100, 
ab7671, Clone 464.6, Abcam) were used to highlight functional markers. The 
secondary antibody used was an Alexa 488-conjugated goat-anti-mouse IgG 
(Molecular Probes
®
, Life Technologies). Negative control for immunostaining used 
the secondary antibody only. Confocal laser scanning microscopy (Nikon A1R) was 
used to image immunofluorescence.  
3.3.7 Electron microscopy 
Electron microscopy was used to visualise the formation of ultrastructural 
features of RPE cells; cuboidal morphology, apical microvilli, basal infoldings, and 
junctional complexes. Representative cultures were selected for sampling and were 
fixed with a 3 % glutaraldehyde solution. Samples for scanning electron microscopy 
(SEM) were washed with 0.1 M cacodylate buffer, post-fixed in 1 % osmium 
tetroxide in cacodylate buffer for 1 hour, prior to dehydration through sequential 
graded series of ethanol (50 % to 100 %). Finally, samples were immersed in 
hexamethyldisilazane (HMDS) for 1 hour, air dried, mounted on an aluminium stub 
and gold coated. Samples were observed with a FEI Quanta 200 SEM operating at 10 
kV. Samples for transmission electron microscopy (TEM) were washed with 0.1 M 
cacodylate buffer, post-fixed in 1 % osmium tetroxide and 1 % uranyl acetate, and 
dehydrated through a sequential graded series of ethanol. Samples were then 
infiltrated and embedded in Spurr epoxy resin. Ultrathin sections (50 nm to 100 nm) 
were cut, and uranyl acetate and lead citrate stains were applied prior to examination 
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and photography using a JEOL 1400 Transmission Electron Microscope operating at 
80 kV. 
3.3.8 Selective phagocytosis assay 
The phagocytic function of mature RPE cultures was tested by quantifying the 
uptake of highly fluorescent vitronectin-coated polystyrene microspheres (2 µm, 
FluoSpheres, Molecular Probes
®
, Life Technologies). The assay is an established 
protocol (Ainscough et al., 2009) that was designed in our laboratory to exploit the 
known role of the apical transmembrane integrin, V5, which interacts with 
vitronectin to initiate phagocytosis by RPE cells (Nandrot et al., 2006). Briefly, the 
microspheres were treated with vitronectin (20 µg/mL) in 20 mM HEPES binding 
buffer (HBB) and incubated for 1 hour at 37 °C, and blocked with 0.1 % bovine 
serum albumin (BSA, A-7030, Sigma Aldrich) in HBB, incubated for a further hour 
at 37 °C. Fluorescent microspheres treated with 0.1 % BSA in HBB only for the two 
incubation times were used as a negative control. Coated microspheres were exposed 
to representative culture samples for 24 hours at 37 °C. Cultures were then washed, 
fixed in 3.7 % formaldehyde in PBS, stained with Hoechst nuclear dye and imaged 
with confocal laser scanning microscopy (Nikon A1R). 
3.3.9 Growth factor secretion  
The secretion of growth factors by mature cultures was examined using a 
standard ELISA approach. Briefly, the culture medium from the apical and basal 
compartments of representative culture samples was collected 24 hours after 
replacement of media. Commercial ELISA kits for PEDF (#CYT420, Merck 
Millipore), and VEGF (#DY293B, R&D Systems) were used to quantify growth 
factor secretion in culture medium volumes. Five cultures for each membrane type 
were tested using both ELISA kits (samples tested in duplicate). Basal volumes were 
concentrated using centrifugal filters (Amicon
®
 Ultra-4, Ultracel
®
 10K MW, 
regenerated cellulose, Merck Millipore) to reduce the final sample volume to be 
comparable to the apical volume, and for the sample to be concentrated enough for 
the sensitivity range of the commercial ELISA assay kits.  
3.3.10 Statistical analyses 
The ELISA results for growth factor secretion into the apical and basal 
compartment and the apical-basal growth factor ratio for each membrane type were 
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analyzed for statistical significance using a two-way ANOVA followed by a Tukey’s 
multiple comparisons test (GraphPad Prism, V 6).  
3.4 RESULTS 
3.4.1 Cultivation of RPE cells on fibroin membranes 
Long-term cultivation (16 weeks) of ARPE-19 cells on fibroin membranes in 
Miller’s medium produced a confluent layer of tightly packed cobblestoned cells 
(Fig. 3.2 A). Approximately 25-50 % of cells displayed pigmentation after 12 weeks 
in culture. The distribution of F-actin filaments after 16 weeks was mostly at cell 
boundaries, but some stress fibres were occasionally seen (Fig. 3.2 C). The 
distribution of ZO-1 was very similar to the localization of F-actin at the epithelial 
cell boundaries (Fig. 3.2 D). Immunostaining for ezrin generally revealed a 
homogenous distribution for this protein, however, relatively intense staining was 
observed adjacent to the apical surface (Fig. 3.2 E). Positive immunostaining for the 
cytokeratin pair 8/18 (Fig. 3.2 F), RPE-65 (Fig. 3.2 G) and Na
+
/K
+
-ATPase (Fig. 3.2 
H) was also observed, with varying levels of intensity depending upon the Z-level of 
confocal sectioning.  
Analysis of parallel cultures prepared on commercial polyester membranes 
(Fig. 3.3) revealed similar results to those for cultures grown on fibroin membranes. 
Once again, cultures developed into a cobblestoned morphology and pigmentation 
was evident within a similar time frame (by approximately 12 weeks) (Fig. 3.3 A). 
Markers of cell structure (F-actin, ZO-1, ezrin, and cytokeratin pair 8/18) were 
generally similar in distribution to those observed in cultures grown on fibroin (Fig. 
3.3 C, D and G respectively). Fewer stress fibres, however, were observed and 
staining for ZO-1 was less intense at cell boundaries than was observed using fibroin 
membranes. Confocal sectioning in the Z-axis once again revealed most intense 
staining for ezrin at the apical surface (Fig. 3.3 E). Positive staining was also 
confirmed for the metabolic markers RPE-65 and Na
+
/K
+
-ATPase (Fig 3.3 panels G 
and H). The distribution patterns for these markers were noticeably more 
homogenous than for cultures grown on fibroin membrane.  
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Figure 3.2. Morphology of RPE cells (ARPE-19) after 16 weeks cultivation on 
fibroin membranes. (A) A cobblestoned morphology accompanied by pigmentation 
(labelled by arrows; P) was evident within 12 weeks. Assessment of fixed cultures 
after 16 weeks revealed: a mostly circumferential arrangement of F-actin with 
occasional stress fibres (C; stained with rhodamine phalloidin). Positive 
immunostaining (relative to negative control; B), for ZO-1 (D), ezrin (E), cytokeratin 
pair 8/18 (F), RPE-65 (G) and Na
+
/K
+
-ATPase (H) was evident. The distribution for 
ZO-1 staining resembled the circumferential distribution for F-actin (with C and D 
displaying identical field of cells). The most intense staining for ezrin was observed 
at the apical cell surface (refer Z-Y panel at right of panel E). Hoechst nuclear dye is 
displayed as the blue counter-stain in panel B and panels D to H. The scale bar 
represents 100 µm and applied to all images. 
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Figure 3.3. Morphology of RPE cells (ARPE-19) after 16 weeks cultivation on 
commercial polyester membranes (Transwell
®
). (A) A cobblestoned morphology 
accompanied by pigmentation (labelled by arrows; P) was evident within 12 weeks. 
Assessment of fixed cultures after 16 weeks revealed: a mostly circumferential 
arrangement of F-actin with less evidence of stress fibres (C; stained with rhodamine 
phalloidin). Positive immunostaining (relative to negative control; B), was again 
observed for ZO-1 (D), ezrin (E), cytokeratin 8/18 (F), RPE-65 (G) and Na
+
/K
+
-
ATPase (H). As for cultures grown on fibroin, the distribution for ZO-1 staining 
resembled the circumferential distribution for F-actin (with C and D displaying 
identical field of cells). The most intense staining for ezrin observed at the apical cell 
surface (refer Z-Y panel at right of panel E). While staining for cytokeratin pair 8/18 
varied according to Z-axis within each cell (F), a more homogenous distribution was 
observed for RPE-65 and Na
+
/K
+
-ATPase (G and H respectively). Hoechst nuclear 
dye is displayed as the blue counter-stain in panel B and panels D to H. The scale bar 
represents 100 µm and applied to all images. 
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3.4.2 Ultrastructure of RPE cells established on fibroin membrane 
In parallel with the above studies, several replicate cultures established on each 
type of membrane were processed for scanning and transmission electron 
microscopy (Fig. 3.4). SEM revealed numerous projections of the cell surface for 
cultures established on both membrane types (Fig. 3.4 A to D). The projections 
emanating from cultures grown on polyester membranes were less dense and the 
surface of the culture generally displayed a flatter profile with cell margins being less 
well defined (Fig. 3.4 panels B and D). This flatter profile for cultures grown on 
polyester membranes was confirmed by TEM (Fig. 3.4 F), however, differences in 
apical cell projections were less apparent when viewed from this angle. Despite these 
subtle variations, the general ultrastructure of cultures grown on either membrane 
was generally similar. Importantly, high magnification examination of cultures 
grown on fibroin membranes revealed the existence of electron dense material near 
the apical cell borders akin to junctional complexes (Fig. 3.4 G). Examination of the 
basal cell surface revealed numerous infolding (Fig. 3.4 H). The basal surface of the 
cells grown on either membrane was separated from the substrate by a layer of 
extracellular matrix components approximately 1 m thick (Fig. 3.4 panels F and H). 
3.4.3 Examination of trans-epithelial resistance 
Throughout the 16 weeks of study, cultures established on both membrane 
types were routinely assessed for evidence of developing increased TER. Membranes 
maintained under culture conditions but without cells were also routinely measured 
as controls. Fibroin membranes alone set up in our custom-designed Teflon
®
 
chambers displayed an endogenous level of TER between 250-300 Ohms per cm
2
 
(Ωcm2) throughout the 16 weeks of study. In contrast, the TER for polyester 
membranes fluctuated between 170-250 Ωcm2. No significant change in TER was 
detected for ARPE-19 cultivated on either membrane type over time.  
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Figure 3.4. Electron micrographs of RPE cells grown on membranes fabricated from 
fibroin (A and C), or polyester (B and D). Scanning electron micrographs after 16 
weeks in culture show cells that display a surface morphology indicative of normal 
RPE cells. Tight, cobblestoned morphology with dense microvilli-like projections 
can be visualised and uniformly cover the apical surface of the RPE cells grown on 
either material (A and B). Differences in density can be seen when comparing the 
microvilli at 50K magnification (C and D). Transmission electron micrographs show 
morphological features consistent with biological functioning (E-H). Cross-sections 
of apical microvilli-like projections in cultures grown on fibroin membranes (E and 
G), and polyester (F). Electron-dense regions along the plasma membranes of 
adjacent cells are consistent with development of tight junctional complexes (G), and 
the basal surface of cells grown on polyester (F) and fibroin (H) show features of 
membrane infolding and the deposition of material between the cell surface and the 
membrane. 
 60 Research Study One  
3.4.4 Examination of phagocytosis 
Sixteen week-old cultures of ARPE-19 cells grown on either membrane type 
both displayed a marked response to fluorescent polystyrene microspheres coated 
with vitronectin (followed by BSA) (Fig. 3.5). Internalisation of the vitronectin-
coated microspheres was confirmed by confocal laser scanning microscopy (refer X-
Z and Z-Y axis profiles in Fig. 3.5 panels A and B). In sharp contrast, neither culture 
displayed an affinity for microspheres coated with BSA alone and those few 
microspheres that were retained after washing were typically located near the cell 
surface (Fig. 3.5 panels C and D). 
 
Figure 3.5. Selective phagocytosis by mature RPE cells (ARPE-19) grown on 
membranes fabricated from fibroin (A and C), and polyester (B and D). Fluorescent 
microspheres (green) were treated and then exposed to mature RPE cultures 24 hours 
prior to fixation. (A and B) Microspheres were treated with vitronectin, and blocked 
with bovine serum albumin (BSA). (C and D) For control purposes, fluorescent 
microspheres were treated with BSA only. Cultures were imaged using confocal 
laser scanning microscopy, with the side profiles confirming bead engulfment. 
Nuclei are stained with Hoechst nuclear dye (blue). Scale bar represents 100 µm. 
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3.4.5 Examination of growth factor secretion 
Cultures grown on either membrane type secreted significant quantities of 
VEGF and PEDF (Fig. 3.6). In both cases the quantity of PEDF secreted by ARPE-
19 cells was approximately 10 to 50-fold higher than for VEGF (1-5.5 ng/cm
2
 PEDF 
versus 50-100 pg/cm
2
 for VEGF; p < 0.0001). While higher concentrations of PEDF 
were consistently observed in the apical compartments (above the membrane) 
compared to the basal compartments (below the membrane), this was not found to be 
statistically significant. Similar levels of VEGF were observed in both compartments 
for cultures grown on fibroin membrane. A slight but significantly higher (p < 0.01) 
concentration of VEGF was observed in the basal compartment (compared to the 
apical compartment) for cultures grown on polyester membrane. Based on this data, 
the apical-basal ratio of growth factor secretion was calculated for the two substrate 
types. ARPE-19 cells grown on fibroin membranes had a [PEDF/VEGF]Ap ratio = 
53.5, and a [PEDF/VEGF]Ba ratio = 9.8 (p < 0.05). ARPE-19 cells grown on 
polyester membranes had a [PEDF/VEGF]Ap ratio = 70.6, and [PEDF/VEGF]Ba ratio 
= 25.1 (p < 0.05). There was no significant difference between the values for 
[PEDF/VEGF]Ap ratio or [PEDF/VEGF]Ba ratio when comparing the substrate types.  
3.5 DISCUSSION 
A variety of different materials have been proposed as a potential vehicle for 
RPE cell implants, but an optimal candidate has yet to be identified. We have 
previously proposed evaluation of Bombyx mori silk fibroin based on this material’s 
long history of prior clinical use (in the form of silk sutures), favourable mechanical 
properties and amenability to simple manufacturing techniques. We presently 
demonstrate that mature cultures of RPE cells (derived from ARPE-19 cells) grown 
on fibroin membranes, display similar morphological features to those grown in 
parallel on commercial cell culture membranes constructed from porous polyester. 
Moreover, we have demonstrated similarities in key RPE functions when cells are 
grown on either type of material. While minor differences in RPE morphology and 
function were observed when cultures grown on fibroin or polyester membranes 
were compared, we consider that the performance of fibroin is sufficient to warrant 
advancement to pre-clinical studies of this material as a vehicle for RPE cell 
implantation.  
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The ARPE-19 cell line is widely used as a model of human RPE cell function, 
however, it is seldom grown using best current standard practices, i.e. with the use of 
defined media formulations, porous supports permitting separation of apical and 
basal compartments, and extended culture periods for maturation (Pfeffer & Philp, 
2014).  In our previous studies we utilised a growth medium as recommended by the 
original authors (Dunn et al., 1996), however, it has since become apparent that a  
 
Figure 3.6. Growth factor secretion by mature RPE cells (ARPE-19) grown on 
membranes fabricated from fibroin (A), and polyester (B). Commercial ELISA kits 
(for VEGF and PEDF) were used to quantify the concentration of growth factors 
secreted in culture medium collected from the apical and basal compartments 24 
hours after media replacement. Five cultures for each membrane type were tested 
using both ELISA kits (samples tested in duplicate). Data presented is mean (+ 
standard error of mean) with VEGF data on left axis and PEDF data corresponding to 
right axis. Significant difference in growth factor concentration comparing ‘VEGF vs 
PEDF’ for both membranes (p < 0.0001). Significant difference between apical and 
basal compartment found for ‘VEGF + polyester membrane’ only (*p =0.0084). 
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different medium (as described in detail by Maminishkis et al., 2006) is required to 
assure a mature RPE morphology using conventional cell culture incubator settings. 
Using this approach we have demonstrated clear evidence of mature RPE 
morphology for cultures grown on fibroin membranes coated with extracellular 
matrix components extracted from human placenta. In a sense, the fibroin membrane 
is therefore being exploited for its mechanical properties as a tissue scaffold rather 
than a material intended to directly interact with the cells, i.e. it is used as a Bruch’s 
membrane prosthesis.  
Measurement of TER using a voltohmmeter is regularly performed to assess 
the maturity and function of RPE cells. The principle behind these measurements is 
that the electrical resistance of RPE cultures increases during the development of 
tight junctions between neighbouring cells (Sonoda et al., 2009). While ARPE-19 
cells lack the full complement of proteins required to produce mature tight junctions 
(Luo et al., 2006), the distribution of F-actin filaments and ZO-1 observed in our 
cultures indicates that a similar degree of partial-tight junction formation is observed 
when cultures grown on fibroin or polyester membranes were compared. As 
expected, we were unable to detect significant increases in TER for cultures grown 
on either test material. Interestingly, the endogenous TER for fibroin membrane (no 
cells) was only marginally higher than the endogenous TER recorded for the 
polyester membrane (no cells).   
Despite the above limitations, the long term cultures of ARPE-19 cells grown 
on fibroin membranes demonstrated multiple features associated with normal mature 
RPE cell morphology and function including development of pigmentation and 
apical-basal polarity (demonstrated by apical staining for ezrin and development of 
microvilli-like structures). The functionality of the apical surface is demonstrated by 
the marked phagocytic response to the synthetic fluorescent microparticles coated 
with vitronectin. This assay is based upon the fact that phagocytosis of photoreceptor 
outer segments (POS) in vivo is initiated via binding to the vitronectin receptor v5 
integrin. While there are limitations with using materials other than actual POS, this 
approach does have the advantage of enabling inclusion of a negative control 
(particles coated only with BSA). In any case, future studies of RPE cell function 
when grown on fibroin membranes should include an analysis of POS uptake. 
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Secretion of pro- and anti- angiogenic growth factors is vital to maintaining a 
healthy outer blood-retinal barrier. The RPE normally contributes to this balance by 
secreting the pro-angiogenic factor VEGF and the antiangiogenic factor PEDF 
(Strauss, 2005). While the secretion of VEGF across Bruch’s membrane is 
considered important for maintaining a normal choriocapillaris, apical secretion of 
PEDF discourages aberrant growth of blood vessels into the subretinal space (a 
neuroprotective component of PEDF also nourishes the sensory retina) (Kay et al., 
2013). It is therefore significant to note that mature RPE cultures established on 
fibroin membrane secrete higher amounts of PEDF than VEGF and that the former 
tends to be preferentially released into the apical compartment. Moreover, while the 
polyester membranes appear to be more permeable to VEGF, the fibroin membranes 
supported sufficient diffusion of this angiogenic factor into the basal compartment to 
produce an apparent equilibrium with the apical compartment. The apical-basal ratio 
of growth factor secretion by ARPE-19 cells grown on both substrate types, are 
similar to values that have been reported previously (Maminishkis et al., 2006). On 
this basis, we predict that the balance of VEGF and PEDF secreted by RPE cells 
grown on fibroin membrane would be consistent with the requirements of a healthy 
outer blood-retinal barrier following implantation.  
Notwithstanding the positive considerations above, there remain opportunities 
to improve the formulation of fibroin membranes as a vehicle for RPE cell 
implantation. Human recombinant tropoelastin has recently been shown to alter the 
elastic properties of fibroin membranes when the two proteins are blended together 
in solution (Hu et al., 2011; Hu et al., 2010). Moreover, since elastin fibers are a 
prominent feature of the inner Bruch’s membrane structure, a tri-layered structure 
consisting of fibroin-tropoelastin-fibroin might better replicate the functional 
requirements of a prosthetic Bruch’s membrane. The outer coating of fibroin 
membranes also presents opportunities for optimization. For example, since fibroin is 
a protein, peptides of desired design could be readily conjugated to the surface of 
membranes using relatively simple chemical methods including reaction with 
terminal amine groups. Indeed, each side of the fibroin membrane could be 
specifically tailored to encourage attachment and growth of RPE cells and choroidal 
cell types respectively. 
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3.6 CONCLUSIONS 
In summary, we conclude that the behaviour of mature RPE cell cultures 
established on fibroin membranes is essentially equivalent to that displayed by best 
practice cultures grown on porous polyester membranes. Unlike the latter research 
material, however, fibroin membranes are fabricated entirely from a protein with low 
immunogenicity and at a thickness comparable to healthy Bruch’s membrane, which 
makes this material an attractive choice of vehicle for RPE cell implantation. Future 
refinements in the performance of fibroin membranes should also be possible 
through the replacement of crude ECM coatings, as used presently, with desired 
combinations of medical grade proteins or synthetic peptide analogues. Ultimately, 
the potential of fibroin membranes as a vehicle for RPE cell implants will need to be 
examined in vivo. To this end, the present data encourages advancement to a 
preclinical study of fibroin safety and feasibility as a vehicle for RPE implantation 
into the subretinal space. 
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Incorporation of human recombinant tropoelastin into silk fibroin 
membranes with the view to repairing Bruch’s membrane 
4.1 ABSTRACT 
Bombyx mori silk fibroin membranes provide a potential delivery vehicle for 
both cells and ECM components into diseased or injured tissues. We have previously 
demonstrated the feasibility of growing RPE cells on fibroin membranes with the 
view to repairing the retina of patients afflicted with AMD. The goal of the present 
study was to investigate the feasibility of incorporating the ECM component elastin, 
in the form of human recombinant tropoelastin, into these same membranes. Two 
basic strategies were explored: (1) membranes prepared from blended solutions of 
fibroin and tropoelastin, and (2) layered constructs prepared from sequentially cast 
solutions of fibroin, tropoelastin and fibroin. Optimal conditions for RPE attachment 
were achieved using a tropoelastin-fibroin blend ratio of 10 to 90 parts by weight. 
Retention of tropoelastin within blend and layered constructs was confirmed by 
immunolabelling and Fourier-transform infrared spectroscopy (FTIR). In the layered 
constructs, the bulk of tropoelastin was apparently absorbed into the initially cast 
fibroin layer. Blend membranes displayed higher elastic modulus, percentage 
elongation and tensile strength (p < 0.01) when compared to the layered constructs. 
RPE cell response to fibroin membranes was not affected by the presence of 
tropoelastin. These findings support the potential use of fibroin membranes for the 
co-delivery of RPE cells and tropoelastin. 
4.2 INTRODUCTION 
While strategies for tissue regeneration are often based upon the replacement 
of lost cells, such efforts often ignore the significant contribution of ECM 
components to tissue structure and function. A good example of this problem is 
illustrated through the attempts to treat AMD of the retina. In short, although the 
pathology of AMD involves significant changes to both cellular and ECM 
components, most efforts to date have been largely focused on replacing only the 
cellular components and especially RPE cells (Binder et al., 2007; da Cruz et al., 
2007; Jha & Bharti, 2015; Lee & Maclaren, 2011). In doing so healthy RPE cells are 
ultimately delivered into sites containing an abnormal composition and arrangement 
of ECM components. In order to address this issue, a number of groups have 
explored the potential of a variety of biomaterials as temporary ECM substitutes to 
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support the RPE cells during cultivation and implantation (Binder, 2011; Hynes & 
Lavik, 2010). In our case, we have focused on the development of a substitute 
prepared from the silk structural protein, fibroin (Harkin et al., 2011; Shadforth et al., 
2012). Using this strategy, we have demonstrated the feasibility of establishing 
functional monolayers of RPE cells grown on fibroin membranes (Chapter 3). These 
RPE monolayers share several important features with those found within the healthy 
retina including apical-basal polarity, patterns of growth factor secretion and 
phagocytic function. As such, fibroin membranes have potential as a vehicle for 
implanting cultured RPE cells into AMD patients. Since the fibroin membranes will 
eventually degrade, the incorporation of ECM components, or their precursors, 
within the fabricated membranes may further facilitate subsequent development of a 
more permanent ECM. The aim of the present study, therefore, was to examine the 
feasibility of incorporating ECM components found naturally within the outer retina. 
More specifically, we have examined the incorporation of the precursor protein from 
which elastin fibres are produced, tropoelastin (Wise et al., 2009). 
Our focus on tropoelastin arises from considering the composition of the ECM 
that resides immediately posterior to the RPE, a structure known as Bruch’s 
membrane. A functional, native Bruch’s membrane contains an elastin fibre-rich core 
that is thought to facilitate tissue compliance during cycles of tissue expansion and 
recoil as blood flows through the adjacent capillaries of the choriocapillaris (Booij et 
al., 2010). The elastic properties of Bruch’s membrane may also serve to protect the 
delicate connections that exist between RPE cells and the adjacent photoreceptor 
cells (Leure-duPree, 1968). However, age-related changes, such as the accumulation 
of abnormal deposits referred to as drusen, disrupt the biochemical and mechanical 
properties of Bruch’s membrane (Booij et al., 2010). Moreover, an aged Bruch’s 
membrane deters the survival of both endogenous as well as implanted RPE cells 
(Bhutto & Lutty, 2012; Sugino et al., 2011; Tezel et al., 1999; Tezel & Del Priore, 
1997, 1999). Importantly, RPE cells have been shown to produce microfibrils, and 
lysyl oxidase, the enzyme responsible for converting tropoelastin into elastin fibres 
(Wachi et al., 2005). Thus, by implanting RPE cells in conjunction with tropoelastin 
it may be possible to regenerate the core element of a functional, native Bruch’s 
membrane following degradation of the fibroin-based delivery template. In addition, 
since tropoelastin shares similar elastic properties with elastin (Wise et al., 2009), it 
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may also be possible to create fibroin-tropoelastin constructs with physical and 
mechanical properties that are more favorable for establishing and implanting RPE 
cell cultures than constructs based solely on fibroin. 
Two strategies for incorporating tropoelastin into fibroin membranes were 
examined in this study. Membranes were produced from fibroin solutions 
supplemented with recombinant human tropoelastin (fibroin-tropoelastin blend) or 
prepared from alternating cast solutions of fibroin and tropoelastin (layered 
approach). In the case of the blend, we commenced by optimizing the amount of 
tropoelastin that can be added to fibroin solution without negatively impacting on the 
attachment of RPE cells to the resulting membranes. Freestanding membranes were 
subsequently produced from the optimal blend formulation, and by using the layered 
approach. The two types of biomaterial membrane were subsequently compared in 
parallel with standard fibroin membranes using a variety of criteria including 
morphology (scanning electron microscopy), secondary structure (Fourier-transform 
infrared spectroscopy-attenuated total reflectance, FTIR-ATR), the distribution of 
tropoelastin (immunofluorescence), the cultivation of RPE cells, and mechanical 
properties. These studies led to some unexpected findings, especially in regard to 
how tropoelastin in solution interacts with cast fibroin membranes. 
4.3 MATERIALS AND METHODS 
4.3.1 Production of aqueous solutions of fibroin 
The procedure has been previously described in detail by our group (Chirila et 
al., 2008). Briefly, dried Bombyx mori silkworm cocoons (Tajima Shoji Co. Ltd., 
Yokohama, Japan) were boiled in a solution of sodium carbonate containing 0.85 g 
of salt for each gram of cocoon material. This procedure removed the sericin outer 
coat from the core fibroin protein. The resulting fibrous material was washed and 
dried, and then dissolved (at 60 °C for 4 hours) in a concentrated solution of lithium 
bromide (9.3 M) to obtain a silk concentration of approximately 10 % wt./vol. The 
fibroin solution was subsequently filtered using syringe filters in succession with 
pore size 0.7 µm and 0.2 µm. This step is performed slowly to avoid shearing forces 
that could promote spontaneous gelation. The filtrate was dialyzed against water 
using a dialysis cassette with a molecular mass cut-off of 3.5 kDa (Slide-A-Lyzer, 
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Pierce Biotechnology) using 6 changes of water over 3 days. The resulting fibroin 
solution was filtered again as above and used to produce fibroin membranes. 
4.3.2 Preparation of films cast in TCP wells: fibroin and tropoelastin solutions 
blended in different ratios 
Films of fibroin and tropoelastin were prepared by the method reported by (Hu 
et al., 2011) with some modifications. Briefly, tropoelastin (freeze-dried powder) 
was dissolved in cold MilliQ water (4ºC) to make the concentration of 1.78 %, and 
kept in an ice bath for 2-3 hours with occasional vortex mixing. The low temperature 
is required to prevent coacervation of the solution (self-aggregation of hydrophobic 
domains). The tropoelastin solution was slowly added to a cold fibroin solution 
(1.78%) by a pipet, and mixed by inverting the tube slowly. The volume ratio of the 
fibroin solution to the tropoelastin solution was mixed over the range 90:10, 75:25, 
and 50:50. The mixture solutions were cast into wells of 24-well TCP plates and 
dried in a fan-driven oven for 12 hours at room temperature. For structural 
stabilization of fibroin with tropoelastin, β-sheet formation was induced by water 
annealing the plates in a vacuum oven at 60 ºC, -80 kPa with ~100 mL water in a 
beaker, for 12 hours, followed by drying in a fan-driven oven for 12 hours at room 
temperature. 
4.3.3 Cell culture of human RPE cell line, ARPE-19 
ARPE-19 cells were routinely cultured using the Miller’s medium formulation 
(Maminishkis et al., 2006); minimum essential medium, alpha modification (MEM-
α, M-4526) supplemented with N1 supplement (N-6530), glutamine-penicillin-
streptomycin (G-1146), non-essential amino acids (M-7145), taurine (T-0625), 
hydrocortisone (H-0396) and triiodo-thyronin (T-5516). All these components were 
purchased from Sigma Aldrich. This medium formulation allows RPE cultures to be 
incubated at 37 °C using a standard level of 5 % CO2 air. Cultures were established 
in the presence of 10 % FBS, and after 24 hours this serum level was decreased to 1 
%. Stock cultures were fed two to three times per week, and passaged routinely using 
Versene (15040-066, Life Technologies) and TrypLE™ (12563-011, Life 
Technologies), between passages number 23 and 28. An independent STR profile 
analysis of our working stocks by the Garvan Institute of Medical Research revealed 
a 100 % match with reference ARPE-19 cell line CRL-2302. 
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4.3.4 Testing the attachment of RPE cells on films of fibroin and tropoelastin 
blended in different ratios 
The cell attachment was quantified on films prepared by blending solutions of 
fibroin and tropoelastin (section 4.3.2). RPE cells (ARPE-19) were seeded at a 
density of 40,000 cells/cm
2
 and incubated at 37 °C, 5 % CO2 for 4 hours using 
Miller’s medium without serum. Fibroin films and TCP (used with and without 
serum) were used as control substrates for ARPE-19 cell attachment. Each substrate 
type was tested in triplicate, with the experiment performed in triplicate and 
quantified using the Quant-iT PicoGreen
®
 dsDNA kit (Molecular Probes™, Life 
Technologies). 
4.3.5 Preparation of fibroin membranes 
Fibroin membranes were cast using a custom-made casting table as described 
previously by our group (Bray et al., 2011). The thickness of fibroin membranes was 
measured using an upright micrometer and only areas of membrane 3 µm ± 1 µm 
thick were used. For structural stabilisation of fibroin membranes, β-sheet formation 
was induced by the water-annealing of the membranes in a vacuum oven at -80 kPa 
with ~100 mL water (beaker) for 6 hours at room temperature (25 ºC). The 
permeability of fibroin membranes has been previously examined using a horizontal 
diffusion cell using 3 model molecules (Bray et al., 2011). 
4.3.6 Preparation of freestanding membranes of fibroin and tropoelastin, 
proteins blended in 90:10 solution ratio 
Freestanding membranes of fibroin and tropoelastin blend were prepared by the 
method outlined above (section 4.3.2), except that only the 90:10 volume ratio of the 
fibroin solution to the tropoelastin solution was used. For casting, 45-mm Petri 
dishes were first coated with a Topas
®
 (a commercial hydrophobic cyclic olefin 
copolymer) film (1 mL of a 7 % solution) by the evaporation from a solution in 
cyclohexane. The Topas
®
 solution forms a hydrophobic film on the glass, facilitating 
easy removal of the membranes from the dishes later. The mixture solution (1.78 %, 
1 ml) was poured into the dish, and dried in a fan-driven oven for 12 hours at room 
temperature. For structural stabilisation of fibroin with tropoelastin, the blend 
membranes were water annealed using a vacuum oven with a container of water and 
kept at -80 kPa at 60 ºC for 12 hours, followed by drying in a fan-driven oven for 12 
hours at room temperature. The membranes were peeled from the Topas
®
 film and 
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used for cell culture and mechanical testing. The thickness of the membranes used 
was 2-3 µm. 
4.3.7 Preparation of freestanding layered (fibroin-tropoelastin-fibroin) 
membranes 
Layered membranes were fabricated using separate aqueous solutions of 
fibroin and tropoelastin, layered in sequence and followed by stabilisation after each 
layer. Before casting any protein solutions, 45-mm Petri dishes were first coated with 
a Topas
®
 film. The layered membrane was prepared as following. Firstly, 1 mL of 
0.59 % fibroin solution was cast and dried in a fan-driven oven at room temperature 
overnight, followed by water annealing in a vacuum oven with a beaker of water at -
80 kPa at room temperature, for 6 hours. Then 1 mL of 0.59 % tropoelastin solution 
was cast and dried at 4˚C for 4 days. The tropoelastin layer was stabilized by 
treatment with methanol (5 mL) for 24 hours at room temperature. Finally, 1 mL of 
0.59 % fibroin solution was cast on top of the tropoelastin layer, and stabilized by 
water annealing as above. The volumes used were calculated to generate 1 µm-thick 
layers of each protein, which would result in a 3 µm-thick layered membrane. A 1 
µm-thick membrane of tropoelastin was cast and was not treated with methanol 
(untreated) as a comparison for FTIR-ATR studies. 
4.3.8 Suspension of the membranes in custom-made Teflon® chambers 
Discs (16-mm diameter) of biomaterial membrane were inserted into custom-
made chambers designed by our group, which are manufactured from interlocking 
Telfon
®
 rings specifically for cell culture use (Fig. 3.1). The combined membrane 
and chamber were sterilised together by immersion in 70 % ethanol for 1 hour at 
room temperature, air-dried and washed thoroughly with PBS. The custom-made 
chamber suspends the biomaterial membrane (reminiscent of the commercially 
available Transwell
®
 insert system) creating an apical compartment (upper chamber) 
and a basal compartment (lower chamber) on either side of the membrane. This 
culture setup is required for the development of a polarised epithelial culture. 
4.3.9 Visualization of tropoelastin within the membranes using 
immunofluorescence 
Samples of fibroin, blend, and layered membranes were incubated with a 
primary monoclonal antibody to tropoelastin (BA4, 1:50, ab21599, Abcam). The 
secondary antibody used was an Alexa 488-conjugated goat-anti-mouse IgG 
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(Molecular Probes
®
, Life Technologies). Negative controls for immunostaining were 
incubated with the secondary antibody only. Confocal laser scanning microscopy 
(Nikon A1R) was used to image immunofluorescence. 
4.3.10 Testing cell growth of RPE cells on the membranes 
Cell growth on the fibroin, blend, and layered membranes was compared and 
quantified. RPE (ARPE-19) cells were seeded (4,000 cells/cm
2
) on the discs (6-mm 
diameter) of different biomaterial membranes and evaluated for total cell numbers, 
72 hours after seeding using the Quant-iT PicoGreen
®
 dsDNA kit (Molecular 
Probes™, Life Technologies). This experiment was performed in triplicate using 
discs of freestanding biomaterial membrane (samples tested in triplicate) held down 
rubber o-rings in the wells of 96-well plates. 
4.3.11 Extended culture of RPE cells on the membranes 
RPE (ARPE-19) cells were seeded (10,000 cells/cm
2
) onto the apical surface of 
biomaterial membranes suspended in Teflon
®
 chambers (section 3.8). All membrane 
types; fibroin, blend, and layered membranes, were precoated with a commercial 
Collagen I solution obtained from porcine origin (0.3 mg/mL, Cellmatrix
®
, Nitta 
Gelatin Inc., Osaka, Japan) diluted in MilliQ water. Cultures were incubated at 37 °C 
and 5 % CO2, and culture media was changed twice weekly. Phase contrast light 
microscopy was used to examine the cultures over a two month culture period. 
4.3.12 Fourier-transform infrared spectroscopy of the membranes 
The FTIR-ATR spectra of the membranes (fibroin, blend, and layered) and 
tropoelastin were collected using a Nicolet FTIR spectrometer (Thermo Electron 
Corp, Waltham, MA, USA), equipped with a Nicolet Smart Endurance diamond 
ATR accessory. Each spectrum was obtained by co-adding 64 scans over the range 
of 4,000 to 525 cm–1 at a resolution of 8 cm–1. The OMNIC 7 software package 
(Thermo Electron Corp, Waltham, MA, USA) was used to analyze and plot the 
spectra. 
4.3.13 Mechanical testing of the membranes 
Strips (1×3 cm) were cut from each membrane type and subjected to tensile 
measurements in an Instron 5848 micrometer, equipped with a 5 N load cell and a set 
gauge distance of 14 mm. The membranes were mounted in pneumatic grips and 
submersed in PBS at 37 ºC in a BioPulsTM unit for 5 minutes prior to testing. Stress-
 Research Study Two 77      
strain plots were recorded, and the Young’s moduli were computed in the linear 
region. The mean values were calculated from results generated by 4-6 
measurements for each specimen. In addition, cyclic tensile loading/unloading 
testing was carried out to evaluate recovery behaviour. The testing experiments were 
set up as above. However, the following method profile was used: the repeated cyclic 
loading/unloading was performed at strain of 20 % in the stress-strain curve, which is 
the linear region, with ± 5% strain of loading/unloading and the rate of 14 mm/min. 
The number of cycles performed was 200 cycles. Four measurements were 
performed for each specimen. From stress-strain plots, the areas under the curve of 
cycles 10 and 200 were calculated and used to evaluate deformation using the 
following equation:  
Deformation (%) = ((Area cycle 10 –  
4.3.14 Statistical analyses 
Results from cell attachment and growth assays were analyzed for statistical 
significance using a two-way ANOVA followed by a Tukey’s multiple comparisons 
test (with the two variables being either “substrate and serum” or “substrate and 
time”). Mechanical testing data were analyzed using a one-way ANOVA with 
Tukey’s test comparing membrane types (with the variable being “membrane type”). 
Recoil testing data for fibroin and blend membranes were analyzed using an unpaired 
t test (since comparing only two independent samples).  All statistical analyses was 
performed using GraphPad Prism, V 6. 
4.4 RESULTS AND DISCUSSION 
4.4.1 Properties of fibroin and tropoelastin solutions 
During their extraction from silkworm cocoons (Wray et al., 2011), a 
significant proportion of the native fibroin proteins (heavy chain 350 kDa and light 
chain 26 kDa) were cleaved into fragments of varying molecular weights (Fig. 4.1). 
In contrast, human tropoelastin produced via recombinant DNA technology (Martin 
et al., 1995) displayed a single band by gel electrophoresis, at approximately 55 kDa 
(Fig. 4.1). The aqueous solutions of fibroin and tropoelastin mixed readily with 
increasing ratios of up to 50% tropoelastin by weight. Phase separation was observed 
when combining solutions at 10 % tropoelastin by weight (resulting in a cloudy 
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solution), however the resulting dried films were transparent and smooth when cast 
in plastic (polystyrene) tissue culture dishes.  
 
Figure 4.1. Relative molecular weight distribution for purified native Bombyx mori 
silk fibroin (middle lane) and recombinant human tropoelastin (right lane) as 
displayed by gel electrophoresis. While the extracted fibroin proteins present as a 
broad range of peptide fragments, recombinant human tropoelastin has a defined 
molecular weight of approximately 55 kDa. The left hand lane shows a selection of 
molecular weight markers. 
4.4.2 Effect of tropoelastin on RPE cell attachment to fibroin 
Since fibroin supports the attachment and growth of RPE cells (Shadforth et 
al., 2012) and tropoelastin has also been shown to positively influence cell 
attachment (Hu et al., 2011, 2010), we examined different blend ratios of fibroin and 
tropoelastin with the goal of identifying an optimal formulation for the resulting 
blend membrane. As demonstrated in Fig. 4.2, a consistent trend was observed 
towards an optimal RPE cell attachment (as defined by DNA content), in either the 
presence or absence of serum (10% v/v), using a tropoelastin-fibroin ratio of 10 to 90 
parts by weight. This result was consistent with prior reports (Hu et al., 2011) and 
has been explained as the optimal ratio between the two proteins. 
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Figure 4.2. Comparison of cell attachment of retinal pigment epithelial cell line 
(ARPE-19) on tissue culture plastic (TCP) coated with either fibroin solution, or 
fibroin mixed with increasing concentrations of tropoelastin (proteins blended in 
solution before coating TCP). Evidence of cell attachment was examined after 4 
hours in either the presence or absence of 10 % (v/v) fetal bovine serum (with 
washing prior to measurement). Each substrate was tested in triplicate. Bars represent 
mean values (+ standard error of the mean) from three experiments. The difference 
between fibroin with 10 % tropoelastin used in the presence of serum and the other 
identified bars was statistically significant (p < 0.05). 
4.4.3 Gross morphology of the freestanding membranes 
Having established the optimal blend ratio of fibroin to tropoelastin for RPE 
cells, we proceeded to test the feasibility of producing freestanding membranes from 
the optimal blend, as well as layered constructs produced by sequential addition and 
drying/stabilization of aqueous solutions containing each protein (fibroin followed by 
tropoelastin, then fibroin again). Both types of membrane were prepared in glass 
Petri dishes coated with Topas
®
 polymer as described previously (Bray et al., 2013). 
In brief, the Topas
®
 coating facilitated the subsequent removal of fibroin-based 
membranes from the glass Petri dishes and was itself delaminated easily leaving 
behind the protein membranes. The membranes produced from the optimal blend 
(Fig. 4.3 B) or by layering (Fig. 4.3 C) were physically comparable to the standard 
fibroin membranes produced routinely in our laboratory (Fig. 4.3 A). All membranes 
were transparent and could be cut into the 16-mm diameter discs required for our 
custom-designed Teflon
®
 cell culture chambers (Fig. 3.1). Nevertheless, the layered 
membranes (Fig. 4.3 C) were noticeably more brittle during excision resulting in 
discs with uneven edges (Fig. 4.3 C). While no layers were evident within the 
membranes examined by scanning electron microscopy (SEM) following freeze 
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fracture (Fig. 4.3 D to F), a distinct band of positive immunolabelling for tropoelastin 
was observed within the layered construct by confocal fluorescence microscopy (Fig. 
4.3 I). In contrast, an uneven distribution of staining for tropoelastin was observed 
within the blend membrane (Fig. 4.3 H). Unexpectedly, only a single band of fibroin 
autofluorescence was observed within the layered constructs (Fig. 4.3 I). This result 
initially suggested to us that perhaps one of the fibroin layers had detached during 
handling, but repeated attempts using multiple samples revealed the same result. 
Moreover, no evidence of a detached fibroin sheet was observed in any sample 
mounted for confocal microscopy. We therefore embarked upon an FTIR analysis of 
the layered composites to determine the fate of the apparently “missing” third layer. 
 
Figure 4.3. Physical appearance of membranes prepared from either fibroin alone (A, 
D and G), tropoelastin-fibroin blend (10:90 ratio) (B, E and H), and layered solutions 
of fibroin and tropoelastin (C, F and I). (A-C): gross appearance of each membrane 
when placed over printed text (16-mm diameter discs). (D-F): internal structures 
revealed by scanning electron microscopy following freeze-fracture. (G-I) 
Visualization of tropoelastin (green) by immunolabelling and confocal fluorescence 
microscopy (the presence of fibroin revealed as blue autofluorescence). 
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4.4.4 Analysis of membrane structure by Fourier-transform infrared 
spectroscopy-attenuated total reflectance, “FTIR-ATR” 
The FTIR-ATR spectra in the range of 1800-950 cm-1 were used to examine 
the surface structure of the different biomaterial membranes (Fig. 4.4 A). The amide 
I region between 1720 and 1580 cm-1 is traditionally used for analysis of the 
secondary structure in proteins, and this region has been well described for fibroin 
(Hu et al., 2006). In the spectrum of the standard fibroin membrane (water-annealed 
for 6 h at 25 °C) (Fig. 4.4 A, A1), both the amide I band shape and its peak 
maximum at 1640 cm-1 indicate a significant amount of random coil component. 
The fibroin (Fig. 4.4 A, A2) and blend (Fig. 4.4 A, A3), membranes that were water 
annealed for 12 h at 60 °C, revealed a strong band at 1621 cm-1 and a shoulder at 
1700 cm-1, corresponding to β-sheet structures and their aggregates (Hu et al., 2006). 
If the layered (fibroin-tropoelastin-fibroin) membrane truly had three layers as 
expected, both surface spectra should reveal a similar fibroin signature. One side of 
the layered membrane (Fig. 4.4 A, A4) did reveal a fibroin signature similar to those 
described above, however, the other side (Fig. 4.4 A, A5) revealed more pronounced 
β-sheet bands. This may be a result of the additional methanol treatment of the initial 
fibroin layer after tropoelastin was added. The other side (Fig. 4.4 A, A5) also 
revealed two weak bands at 1200 and 1135 cm-1 (indicative of tropoelastin) (Fig. 4.4 
A, A6), suggesting that one side of the layered membrane consists of a mixture of 
fibroin and tropoelastin near the surface. The possibility that the methanol treatment 
might be removing some of the tropoelastin layer was also considered. The 
tropoelastin bands were used to investigate the stability of tropoelastin in two-layered 
(fibroin-tropoelastin) membranes before and after methanol treatment (Fig. 4.4 B). 
The spectrum for the tropoelastin side before methanol treatment (Fig. 4.4 B, B2) 
presented two bands at 1200 and 1135 cm-1 which correspond to the spectrum of the 
untreated tropoelastin membrane (Fig. 4.4 B, B5). After methanol treatment these 
tropoelastin bands had dramatically decreased (Fig. 4.4 B, B4). Indeed, a thin 
membrane (thickness of ~1 µm) of tropoelastin was readily soluble in pure methanol 
which was demonstrated in a separate investigation to confirm FTIR results.  
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Figure 4.4. FTIR-ATR spectra of membranes. A (in the range of 1800-950 cm-1): 
(A1) fibroin membrane (water annealed at 25 °C, 6 h), (A2) fibroin membrane (water 
annealed at 60 °C, 12 h), (A3) blend membrane (fibroin:tropoelastin = 90:10), (A4) 
three-layered membrane – side 1, (A5) three-layered membrane – side 2, (A6) 
tropoelastin membrane (untreated). B (in the range of 1300-1100 cm-1): (B1) two-
layered membrane (untreated) - fibroin side, (B2) two-layered membrane (untreated) 
– tropoelastin side, (B3) two-layered membrane (methanol treated) – fibroin side, 
(B4) two-layered membrane (methanol treated) – tropoelastin side, (B5) tropoelastin 
membrane (untreated).   
In considering the differences in relative molecular weight distributions for 
fibroin and tropoelastin (Fig. 4.1) and our previous studies of fibroin membrane 
permeability (70 kDa using FITC-dextran) (Bray et al., 2011), the following 
explanation for the “missing layer” was devised (Fig. 4.5). When tropoelastin 
solution was cast onto the first fibroin layer it is proposed that some tropoelastin 
penetrated through the loosely stabilized fibroin hydrogel network. These 
tropoelastin molecules were subsequently trapped within the fibroin network by 
drying and treatment with methanol. Hence the first fibroin layer had a well-
distributed content of tropoelastin as demonstrated by immunofluorescence. A small 
proportion of tropoelastin remaining on top of the first fibroin layer is also likely to 
have been washed away by methanol treatment. The final layer applied (second 
fibroin layer) would then appear as a single blue layer by autofluorescence. 
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Figure 4.5. Schematic scenario of the predicted (A) and actual (B) outcomes 
achieved during the creation of a layered membrane of fibroin and tropoelastin. 
Based upon FTIR-ATR data, we propose that the bulk of applied tropoelastin is 
absorbed and subsequently trapped within the initially created fibroin membrane. 
Therefore, only two main layers are detected by immunofluorescence/microscopy. 
4.4.5 Cytocompatibility of the membranes 
The cytocompatibility of the fibroin, blend and layered membranes was 
examined over an extended culture period using current best practice culture 
conditions (Pfeffer & Philp, 2014). An assessment of cell numbers after three days 
culture (Fig. 4.6 A) was quantified using the PicoGreen
®
 assay (DNA content 
provides an indication of cell numbers). There was no statistically significant 
difference in the number of cells attached across the three biomaterial membrane 
types, and when compared to the TCP control substrate. The RPE cells seeded on 
each membrane type showed a similar appropriate morphology over the extended 
culture period (Fig. 4.6 B to D). 
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Figure 4.6. Retinal pigment epithelial (RPE) cell behaviour on biomaterial 
membranes. Quantification of RPE cell numbers (A) using the PicoGreen
®
 assay 
after 3 days culture on fibroin, blend, and layered membranes. Tissue culture plastic 
(TCP) was included as control substrate. Data presented is mean (+ standard error of 
mean) from three experiments. Phase contrast micrographs of RPE cells after 21 days 
of growth on fibroin (B), blend (C), and layered (D) membranes. The undulating 
nature of the suspended membranes is the reason some areas of panels (B) and (D) 
are out of focus. The scale bar represents 200 µm and applied to the micrographs. 
4.4.6 Mechanical properties of the membranes 
While our primary goal is to use fibroin as a delivery vehicle for tropoelastin, it 
is possible that combining the two proteins may produce changes in mechanical 
properties that impact upon their handling during RPE cell culture and surgical 
implantation. As a consequence we compared the mechanical properties of standard 
fibroin membranes to those displayed by the blend and layered constructs. The 
results (Fig. 4.7) revealed significant differences between the membranes. The 
layered membranes, while considerably thicker than the other membranes (data 
presented as mean values ± standard error of the mean; layered membranes 16.667 ± 
0.639 µm, compared to fibroin membranes water-annealed at 25 °C 3.610 ± 0.369 
µm, fibroin membranes water-annealed at 60 °C 4.612 ± 0.540 µm, and blend 
membranes 6.112 ± 0.362 µm), were also more brittle (Fig. 4.7 B). In contrast, 
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membranes prepared using a 10 % tropoelastin by weight blend with fibroin were the 
stiffest (Fig. 4.7 A), however they were also strong (Fig. 4.7 B) and elastic (Fig. 4.7 
C). The most interesting results were seen in the standard fibroin membranes that 
were water-annealed at 25 ºC. There was no statistical difference between these 
membranes and the fibroin membranes water-annealed at 60 ºC, however they did 
show different properties. The former were the only membranes that had a Young’s 
modulus (Fig. 4.7 A) within the range of native Bruch’s membrane (7-19 MPa; 
(Curcio & Johnson, 2013) and a useful combination of maximum tensile strength 
(Fig. 4.7 B) and elongation properties. This is especially clear when considering 
there was no difference in elongation at break when compared to the blend 
membrane (Fig. 4.7 C). There was also no statistical difference in recoil capacity of 
the fibroin (water-annealed at 25 ºC) and blend membranes after 200 cycles (Fig. 4.7 
D) of stretching. 
 
Figure 4.7. Quantitative comparison of the tensile properties of biomaterial 
membranes. (A) Young’s modulus, (B) maximum tensile strength, (C) elongation to 
break, and (D) deformation/recoil capacity after 200 cycles. Bars represent mean 
values ± standard error of the mean. Asterisks indicate differences are statistically 
significant (*p < 0.05, **p < 0.01, ****p < 0.0001). 
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4.5 GENERAL DISCUSSION AND CONCLUSIONS 
AMD is a leading cause of permanent vision loss in the elderly. Significant 
efforts are therefore underway in countries with ageing populations to address this 
disease. Consideration of the underlying histopathology indicates that therapies 
based upon the replacement of both cellular (e.g. RPE cells) as well as extracellular 
tissue components may well be required. To this end, we have previously 
demonstrated that freestanding membranes prepared from fibroin provide a potential 
vehicle for delivering RPE cells into the subretinal space (Chapter 3). The present 
study builds upon this research by examining the feasibility of incorporating elastin 
(in the form of tropoelastin) into these same fibroin membranes. In doing so, we have 
proposed that fibroin membranes may provide a vehicle for co-delivering RPE cells 
and tropoelastin to the subretinal space. Moreover, since tropoelastin displays similar 
elastic properties to elastin, we considered that the mechanical properties of fibroin 
membranes may be significantly altered when combined with tropoelastin. 
With regard to our first aim, our data confirms the feasibility of incorporating 
human recombinant tropoelastin into fibroin membranes. Varying results, however, 
are achieved according to the methods used. In short, membranes prepared from 
blended solutions of the two proteins displayed a more heterogeneous composition 
than those produced using a sequential layering method. We propose that the patchy 
distribution most likely results from either phase separation or specific molecular 
interactions between the two proteins when present together in solution. By 
comparison, our subsequent analyses by FTIR suggest that the more homogenous 
distribution of tropoelastin achieved using the layering approach is due to absorption 
and subsequent fixation of this protein within the originally cast fibroin membrane 
(by treatment with methanol). This result suggests that membranes prepared via the 
absorption/fixation method should theoretically support a more even profile of 
tropoelastin delivery following implantation to the subretinal space. Nevertheless, the 
choice of technique is also likely to be influenced by consideration of membrane 
mechanical properties. 
Our study of the effects of tropoelastin on the mechanical properties of fibroin 
membranes, when blended, led to some unexpected results. While others have 
reported reduced stiffness of fibroin membranes following inclusion of tropoelastin 
(Hu et al., 2011, 2010), we have presently reported the opposite result. On the 
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surface, this conflicting data seems quite difficult to resolve. A close comparison of 
the methods used, however, reveals several significant variations including the 
source of cocoons, fibroin isolation protocol, water annealing temperature and the 
thickness of membranes used. In our experience, any one of the parameters alone can 
have significant effects on the properties of fibroin membranes. Thus in combination, 
the differing processes could well have been responsible for the variations in 
response to the tropoelastin observed between each study.  
A comparison of blended versus "layered" strategies for incorporating fibroin 
and tropoelastin is also an interesting exercise. On the basis of their superior strength 
and elasticity, it could be concluded that the blended membranes are superior to the 
more brittle "layered" constructs. Nevertheless, a revised formulation whereby the 
tropoelastin is simply absorbed and trapped, without an additional fibroin layer being 
deposited, is worthy of investigation. In any case, the key comparison to make is how 
closely each membrane resembles the mechanical properties of Bruch's membrane. It 
is thus significant that fibroin membranes water-annealed at 25 °C and membranes 
prepared using the layered approach are closest to native Bruch's membrane in terms 
of Young’s modulus (Curcio & Johnson, 2013). Therefore on this basis, and in 
combination with the more uniform distribution of tropoelastin, we propose that the 
layered membranes are at present the better option to pursue in order to address both 
issues of ECM delivery as well as matching the desired mechanical properties. 
Reconstructing both the cellular and ECM components of diseased and injured 
tissues is an important area of tissue engineering and regenerative medicine. The 
incorporation of a tropoelastin component in fibroin membranes, while maybe not 
bestowing benefits to mechanical properties, offers a potential vehicle for the 
delivery of RPE cells and Bruch’s membrane ECM components into the subretinal 
environment of patients with AMD. Future studies will need to investigate the 
suitability of these membranes in a pre-clinical animal model. 
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Chapter 5: Research Study Three 
Development of a cultured tissue substitute for repairing Ruysch’s complex 
5.1 INTRODUCTION 
The previous chapters have shown that fibroin membranes can mimic some 
properties of Bruch’s membrane, including thickness, and mechanical properties. 
They can also support the establishment of a functional monolayer of human RPE 
cells, and also show potential as a vehicle to deliver native ECM components of 
Bruch’s membrane into the subretinal environment.  
The transplantation of RPE cells, and their survival in the subretinal space, has 
long been established in animal models as a viable way to prevent or slow 
photoreceptor degeneration (Binder et al., 2007; da Cruz et al., 2007). However, a 
similar application to human patients is yet to be resolved. Due to the complexity of 
the macula and complications of human ageing, considerations in relation to the 
precise location and placement of the implant as well as consideration for the 
surgical trauma are of vital importance in the development, evaluation and use of a 
viable cell-based therapy (Gouras, 1998). 
A novel approach was proposed by Binder et al. in 2007, outlining how a 
bioengineered complex could be developed with similar considerations. The 
proposed complex would include a functioning monolayer of RPE, a suitable 
biomaterial substitute for Bruch’s membrane (thin, yet mechanically strong and 
permeable) and choroidal vascular endothelial cells that could anastomose with the 
patient’s vasculature, helping to anchor the complex upon implantation. This 
hypothesis is supported by the relative success of RPE-choroid patch transplantation 
approaches, however allowing the potential to use of a fresh source of RPE cells, 
such as pluripotent stem cell-derived RPE cells or adult RPE stem cells.  
Choroidal vascular endothelial cells and RPE cells have been grown together in 
culture previously and the interaction was described by Sakamoto et al. (1995). This 
group highlighted the heterogeneity and organ-specificity of vascular endothelial 
cells, and showed that vessel formation by choroidal-derived vascular endothelial 
cells in vitro is modulated by RPE cells. Both cell types used in this study were 
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isolated from bovine tissue. The presence of the RPE cells promoted angiogenesis of 
the vascular endothelial cells within the collagen type I gel. Unfortunately the culture 
system did not use a substitute for Bruch’s membrane, and there was no physical 
barrier (other than the 50-300 µm collagen gel) between the two cell types. Therefore 
it was not truly representative of the subretinal architecture. 
An alternative RPE-choroidal endothelial cell co-culture model was established 
and described by Fan et al. (2002). The authors put special emphasis on co-culturing 
the cell types with a definite interface between them. Fan and colleagues were able to 
show functional interactions between co-cultured ARPE-19 cells and human primary 
choroidal-derived endothelial cells. Nevertheless their co-culture setup allows these 
interactions to be studied primarily as an in vitro model only, with no ability to use it 
in an in vivo application. The co-cultures were assembled by placing cultures of 
ARPE-19 cells grown on Transwell
®
 filters over human primary choroidal-derived 
endothelial cells sandwiched within a collagen gel coating the TCP surface below. 
There was a functional interface between the two cell types however the complex 
was essentially two parts grown closely together. By this definition, their construct 
cannot be considered as a reconstruction of Ruysch’s complex with a Bruch’s 
membrane substitute. 
 A simpler model of the RPE-Bruch’s membrane-choriocapillaris complex 
was established and described by Hamilton et al. (2007). This in vitro model used 
ARPE-19 cells, denuded human amniotic membrane, and human umbilical vein 
endothelial cells (HUVECs) to replicate the three in vivo layers. Results from this 
group show their trilayer culture is a promising model; however, the use of amnion 
and HUVECs pose several problems. Amnion, like any allogenically derived 
material, could be a source of infection and disease transmission to the eventual 
patient. More importantly, the thickness of amniotic membrane at 60-100 µm is not 
an appropriate substitute for the much thinner native Bruch’s membrane (3 µm). 
Human amniotic membrane has also been found to be a source of growth factors 
(Shao et al., 2004) that could potentially alter the critical balance of growth factors 
required for normal retinal structure and function. Finally, HUVECs, derived from 
the vein of the umbilical cord, are a macrovascular cell type and may well lack the 
specific features required to replicate the distinct and small capillary vessels of the 
choriocapillaris. A microvascular endothelial cell line or specifically choroidal-
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derived endothelial cells like the ones described by Sakamoto et al. (1995) and Fan et 
al. (2002) would be a better representation of the in vivo environment. 
The goal of the present study was therefore to investigate the feasibility of 
incorporating a vascular endothelial cell component to the RPE-fibroin membrane 
complex. In an attempt to accurately replicate the subretinal architecture, choroidal 
vascular endothelial cells were suspended within a collagen gel to create a 3D matrix 
on one side of the fibroin membrane. The effect of mature RPE cells on the 
behaviour of the choroidal vascular endothelial cells was subsequently examined. 
5.2 MATERIALS AND METHODS 
5.2.1 Production of aqueous solutions of fibroin 
The procedure has been previously described in detail by our group (Chirila et 
al., 2008). Briefly, dried Bombyx mori silkworm cocoons (Tajima Shoji Co. Ltd., 
Yokohama, Japan) were boiled in a solution of sodium carbonate containing 0.85 g 
of salt for each gram of cocoon material. This procedure removed the sericin outer 
coat from the core fibroin protein. The resulting fibrous material was washed and 
dried, and then dissolved (at 60 °C for 4 hours) in a concentrated solution of lithium 
bromide (9.3 M) to obtain a silk concentration of approximately 10 % wt./vol. The 
fibroin solution was subsequently filtered using syringe filters in succession with 
pore size 0.7 µm and 0.2 µm. This step is performed slowly to avoid shearing forces 
that could promote spontaneous gelation. The filtrate was dialyzed against water 
using a dialysis cassette with a molecular mass cut-off of 3.5 kDa (Slide-A-Lyzer, 
Pierce Biotechnology) using 6 changes of water over 3 days. The resulting fibroin 
solution was filtered again as above and used to produce fibroin membranes. 
5.2.2 Preparation of fibroin membranes 
Fibroin membranes were cast using a custom-made casting table as described 
previously by our group (Bray et al., 2011). The thickness of fibroin membranes was 
measured using an upright micrometer and only areas of membrane 3 µm ± 1 µm 
thick were used. For structural stabilisation of fibroin membranes, β-sheet formation 
was induced by the water-annealing of the membranes in a vacuum oven at -80 kPa 
with ~100 mL water (beaker) for 6 hours at room temperature (25 ºC). The 
permeability of fibroin membranes has been previously examined using a horizontal 
diffusion cell using 3 model molecules (Bray et al., 2011). 
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5.2.3 Routine RF6A culture 
The microvascular endothelial cell line, RF6A (CRL-1780
™
, ATCC
®
) was 
derived from fetal rhesus monkey (Macaca mulatta). It was used for this study 
because it is a choroidal derived vascular endothelial cell source. The culture 
medium, ‘Endothelial medium’, used with these cells is MCDB 131 Base media 
(Life Technologies) supplemented with 1% glutamine, 1 % penicillin and 
streptomycin, 0.08 % hydrocortisone, 0.1 % EGF, 0.1% heparin, 0.1 % FGF and 10 
% FBS (Gillies et al., 2015). Stock cultures are grown on Attachment Factor (AF, 
Life Technologies). 
5.2.4 Examining RF6A cell attachment and growth on fibroin 
Cell attachment and growth of microvascular endothelial cells on fibroin 
coated with Attachment Factor (AF, Life Technologies) or Collagen I (0.3 mg/mL, 
Cellmatrix
®
, Nitta Gelatin Inc.) was compared and quantified. The microvascular 
endothelial cell line, RF6A cells were seeded at a density of 25,000 cells/cm
2
 and 
incubated at 37 °C, 5 % CO2 for 4 hours using Endothelial medium without serum, 
or for 72 hours using full Endothelial medium (i.e. with 10 % serum). Uncoated 
fibroin and tissue culture plastic were used as control substrates. Both experiments 
were performed in triplicate, with each substrate type tested in triplicate. Relative 
cell numbers were quantified using the Quant-iT PicoGreen dsDNA kit (Molecular 
Probes, Invitrogen, Life Technologies). 
5.2.5  Preparation of Collagen I gel  
The collagen type I solution was polymerised into a gel using the correct pH, 
temperature and physiological solutions as per manufacturer’s instructions. Ice-cold 
collagen type I solution (pH 3.0) was mixed with a 10X sodium chloride solution and 
a Buffer Solution (50 mM sodium hydroxide, 260 mM sodium bicarbonate and 200 
mM HEPES, pH 8.0). Solutions were mixed in a ratio of 8:1:1, and kept ice-cold 
before and after mixing. The collagen gel polymerised when the combined solution 
was transferred to 37 ºC. Collagen fibres were labelled with fluorescein 
isothiocyanate (FITC) by adding a 1 mg/mL concentration of FITC to the Buffer 
Solution. The collagen type I gel solution was then diluted 1:1 with culture medium 
containing the appropriate concentration of cells. Once transferred to 37 °C, the cells 
were suspended within the polymerising collagen gel. 
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5.2.6 Cell culture of human RPE cell line, ARPE-19 
ARPE-19 cells were routinely cultured using the Miller’s medium formulation 
(Maminishkis et al., 2006); minimum essential medium, alpha modification (MEM-
α, M-4526) supplemented with N1 supplement (N-6530), glutamine-penicillin-
streptomycin (G-1146), non-essential amino acids (M-7145), taurine (T-0625), 
hydrocortisone (H-0396) and triiodo-thyronin (T-5516). All these components were 
purchased from Sigma Aldrich. This medium formulation allows RPE cultures to be 
incubated at 37 °C using a standard level of 5 % CO2 air. Cultures were established 
in the presence of 10 % FBS, and after 24 hours this serum level was decreased to 1 
%. Stock cultures were fed two to three times per week, and passaged routinely using 
Versene (15040-066, Life Technologies) and TrypLE™ (12563-011, Life 
Technologies), between passages number 23 and 28. An independent STR profile 
analysis of our working stocks by the Garvan Institute of Medical Research revealed 
a 100 % match with reference ARPE-19 cell line CRL-2302. 
5.2.7 Using fibroin membranes in Teflon® chambers for cell culture 
Discs of ultrathin fibroin membrane (16-mm diameter) were inserted into 
custom-made chambers designed by our group, which are manufactured from 
interlocking Telfon
®
 rings specifically for cell culture use (Fig. 3.1). The combined 
membrane and chamber were sterilised together by immersion in 70 % ethanol for 1 
hour at room temperature, air-dried and washed thoroughly with PBS prior to use. 
The custom-made chamber suspends the fibroin membrane (reminiscent of the 
commercially available Transwell
®
 insert system) creating an apical compartment 
(upper chamber) and a basal compartment (lower chamber) on either side of the 
membrane (Fig. 3.1). This culture setup is required for the development of a 
polarised epithelial culture.  
5.2.8 Longterm culture of ARPE-19 cells on ultrathin fibroin membranes 
ARPE-19 cells were seeded onto the apical surface of ultrathin fibroin 
membranes in chambers at a density of 10,000 cells/cm
2
. Membranes were precoated 
on both sides with the collagen type I solution diluted (1 in 10) in MilliQ water. The 
membranes are coated with the diluted collagen solution and incubated at room 
temperature for 1 hour. The excess solution is removed and membranes are dried at 
room temperature. Membranes are washed twice with culture medium before cell 
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seeding. ARPE-19 cultures were incubated at 37°C and 5% CO2, and were fed twice 
weekly, with Miller medium used in both the apical and basal compartments.  
5.2.9 Co-culture of ARPE-19 cells, RF6As in collagen gel on either side of 
fibroin membrane 
Collagen gel solution was prepared as per section 5.2.5. The mature RPE 
monolayers (established in section 5.2.8) were grown for 2 months before co-cultures 
were attempted. In order for culture conditions to be consistent all chambers were 
inverted. This meant the mature RPE monolayer would now be “underneath” the 
fibroin membrane, facing into the basal compartment of the Teflon
®
 chamber. This 
chamber orientation would allow the RF6A cells in collagen gel to be added to the 
top of the fibroin membrane, and easy monitoring of the collagen gel over the culture 
period. The co-cultures were established using two seeding patterns in an attempt to 
reconstruct choriocapillaris morphology. The first attempt mixed approximately 
4,700 cells in 62.5 µL of culture medium with an equal volume of collagen type I gel 
solution (which equates to 40,000 cells/mL or 25,000 cells/cm
2 
as used in section 
5.3.2).This total volume (125 µL) was added to the apical side of the fibroin 
membrane. The second experimental seeding pattern used 2,500 cells (5,000 
cells/cm
2
) seeded as a monolayer on the apical surface of the fibroin membrane, and 
3,000 cells in a total volume of 62.5 µL (1:1 ratio of culture medium and collagen gel 
solution equalling 48,000 cells/mL or 30,000 cells/cm
2
)  was added after a 2.5 hour 
attachment time. Control cultures were established for both experimental seeding 
patterns, with the same volumes of RF6A cells with collagen gel solution added to 
the apical side of fibroin membranes that did not have a mature RPE monolayer on 
the underside. The diameter of the collagen gel was monitored over the culture 
period, and the maximum time in co-culture was 8 days. 
5.2.10 Confocal microscopy 
Confocal microscopy (Nikon A1R) was used to visualise the three dimensional 
cultures (DIC40X, oil immersion, 1.000 µm steps, 1.0 AU pinhole). Samples were 
stained with Rhodamine Phalloidin (R415, Life Technologies) and Hoechst nuclear 
dye (H1399, Life Technologies) for 1 hour at 37 °C, and mounted on glass slides that 
had been built up so the collagen gel was not squashed. The three dimensional 
structure of the cultures were imaged and visualised using Nikon NIS-Elements 
software. 
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5.2.11 Statistical analyses 
The cell attachment and proliferation data results were analyzed for statistical 
significance using a one-way ANOVA followed by a Tukey’s multiple comparisons 
test comparing substrate type. Statistical analyses were performed using GraphPad 
Prism, V 6. 
5.3 RESULTS 
5.3.1 Cytocompatability of choroidal vascular endothelial cells on fibroin 
The attachment and growth of choroidal vascular endothelial cells (RF6A) on 
fibroin was evaluated, and the effect of different extracellular matrix coatings on the 
fibroin were compared (Fig. 5.1). At 4 hours in serum-free conditions, the attachment 
of cells to fibroin alone, and fibroin coated with AF or collagen type I was 
significantly lower than the attachment to TCP (Fig. 5.1 A). However, after 72 hours 
in the presence of serum, this trend had reversed and the relative total cell numbers 
(relative to the measurement of DNA content) measured on fibroin coated with AF or 
collagen type I was significantly higher than the growth on TCP (Fig. 5.1 B). There 
was no difference in growth between AF and collagen type I, both ECM coatings 
supported similar cell numbers.  
The morphology of the RF6A cells seeded on the different culture substrates 
was visualised by phase contrast microscopy over the time period (Fig 5.2). There 
was no obvious difference in morphology when comparing the different culture 
substrates after 4 hours attachment (Fig. 5.2 A to D). The cells exhibited similar 
stellate morphology with the extension of pseudopodia. Nevertheless, there were less 
rounded cells with halos on TCP (Fig. 5.2 A), which indicates that more cells have 
attached and started to spread out on TCP at this time point in comparison to the 
fibroin alone and coated fibroin substrates (Fig. 5.2 B to D). This result supports the 
relative cell number values recorded (via measurement of DNA content) on the 
different substrates at 4 hours (Fig 5.1 A). The morphology of the cultures at 72 
hours (Fig. 5.2 E to H) also seems to support the relative cell number values (Fig. 5.1 
B). The morphology and density of cells on the fibroin alone, and coated fibroin 
substrates (Fig. 5.2 F to H) were different to the cells on TCP (Fig. 5.2 E). There 
were more spherical cells with halos on the TCP substrate, and the TCP surface was 
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evident between cells. There was no obvious difference in morphology between AF 
and collagen type I coated fibroin substrates (Fig. 5.2 G and H).   
 
Figure 5.1. Comparison of choroidal vascular endothelial cell (RF6A) attachment 
and growth on either fibroin, fibroin coated with Attachment Factor (+AF), or fibroin 
coated with collagen I (+Col I).  Cultures of RF6A were evaluated for (A) cell 
attachment after 4 hours in serum free conditions (with washing prior to 
measurement), and (B) total cell numbers after 72 hours in the presence of 10 % 
(v/v) serum. Tissue culture plastic (TCP) was used as a control substrate. Each 
substrate was tested in triplicate for each time point. DNA content was measured 
using the Picogreen
®
 assay to provide an indication of cell numbers. Bars represent 
the mean values (+ standard error of the mean) from three experiments. Statistical 
difference in means indicated (*p< 0.05, ****p<0.0001). 
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Figure 5.2. Comparison of choroidal vascular endothelial cell (RF6A) attachment 
and growth on either (A and E) tissue culture plastic (TCP), (B and F) fibroin, (C and 
G) fibroin coated with Attachment Factor, or (D and H) fibroin coated with collagen 
I.  Cultures of RF6A were grown without serum for 4 hours (A to D) or 72 hours in 
the presence of 10 % (v/v) serum (E to H). Panel D shows a particularly dense cluster 
of cells however this density was not uniform across the culture substrate. All 
micrographs taken at 20X magnification using phase contrast microscopy. Scale bar 
represents 200 µm and applies to all panels. 
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5.3.2 Morphology of choroidal vascular endothelial cells seeded within a 
collagen type I gel 
Optimisation of choroidal vascular endothelial cells (RF6A) seeding density within 
the collagen gel 3-D matrix was evaluated by comparing the morphology of cells 
with increasing cell density (Fig. 5.3). The higher the initial seeding density, the 
more the collagen gel contracted over 2 weeks in culture (Fig. 5.3 A). As expected, 
when optically sectioned using confocal microscopy, cell numbers increased 
proportionately with the increase in initial seeding density (Fig. 5.3 B to D). 
Although evidence of cell-cell contacts and branching was observed, it was difficult 
to identify specific interactions between the collagen matrix and the cells. 
 
 
Figure 5.3. Choroidal vascular endothelial cells (RF6A) grown in collagen gel. (A) 
Photograph of three collagen gels in 90-mm diameter petri dish. Each gel in (A) 
corresponds to the micrograph directly below. (B to D) Morphology of vascular 
endothelial cells (RF6A) seeded within collagen gels. (B) Seeded with 25,000 
cells/cm
2
, (C) seeded with 50,000 cells/cm
2
, (D) seeded with 100,000 cells/cm
2
. Red 
is F-actin stained with rhodamine phalloidin, and blue is nuclei stained with Hoechst 
nuclear dye. Scale bar represents 50 µm and applies to panels B to D. 
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5.3.3 Labelling the collagen type I gels with fluorescein isothiocyanate (FITC) 
The self-assembly process of collagen fibril formation in vitro was exploited 
by adding a 1 mg/mL FITC solution to the buffer (pH 8.0) solution combined with 
the collagen type I solution. As the gel polymerised the FITC was incorporated into 
the collagen fibrils. When examined using confocal microscopy the gels fluoresced 
green using a 488 nm laser (Fig. 5.4). The addition of FITC did not appear to 
adversely affect cell morphology, and allowed the visualisation of tracks made by 
migrating cells (data not shown) and the interaction of the cells with their three 
dimensional environment. 
 
 
Figure 5.4. Micrographs (imaged using confocal scanning laser microscopy) of 
collagen I gels that have been labelled with fluorescein isothiocyanate (FITC). (A) 
The collagen fibers are clearly identified with FITC labelling (green). (B) The 
processing of this sample has changed the presentation of the collagen fibers, 
however, it has allowed the visualisation of the choroidal vascular endothelial cells 
that have been incorporated into the gel during polymerisation. Red is F-actin stained 
with rhodamine phalloidin, and blue is nuclei stained with Hoechst nuclear dye. Cells 
had been in culture for 3 days. The scale bar represents 50 µm and applies to both 
images. 
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5.3.4 Effect of mature RPE cells on choroidal vascular endothelial cell 
behaviour 
The establishment of the co-cultures was relatively simple, and the fibroin 
membranes acted as a physical barrier between the two cell types. Interestingly, 
when a collagen gel seeded with RF6A cells was polymerised onto a fibroin 
membrane with a monolayer of mature RPE cells on the other side, the collagen gel 
did not contract over 8 days (Fig. 5.5 B and D). In contrast, when the collagen gel 
with RF6A cells was cultured without a RPE monolayer, it contracted after a few 
days and was significantly smaller by 8 days (Fig. 5.5 A and C). This result is 
consistent with earlier experiments (Fig. 5.3). As shown in Fig. 5.6, the difference in 
diameter of the collagen gels with and without a RPE monolayer was statistically 
significant. The morphology of the RF6A cells was also different between treatment 
groups. Specifically, in the presence of the mature RPE monolayer (Fig. 5.7), cells 
exhibited an elongated morphology, and a network of cells had formed parallel to the 
fibroin membrane (Fig. 5.7 B). Without the presence of a mature RPE monolayer, 
however, the RF6A cells clumped together with the collagen fibres localised around 
these cells (Fig. 5.7 A). 
A three dimensional reconstruction (Fig. 5.8) of the co-culture (same culture as 
Fig. 5.7 B), shows the monolayer of RPE cells on the fibroin membrane. Vascular 
endothelial cells, which formed elongated branching networks of cells parallel to the 
fibroin membrane, were observed on the underside of the membrane.   
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Figure 5.5. Comparison of choroidal vascular endothelial cell (RF6A) morphology 
and collagen gel contraction after 8 days in the presence or absence of a monolayer 
of mature RPE cells. An ultrathin fibroin membrane was suspended inside the 
custom-made Teflon chambers. (A and C) A collagen gel seeded with RF6A cells 
polymerised onto fibroin membrane. (B and D) A collagen gel seeded with RF6A 
cells polymerised onto fibroin membrane that had a monolayer of mature RPE cells 
(ARPE-19) on the underside. (A and C) After 8 days the collagen gel has contracted. 
The edge of the collagen gel with cells can be seen in panel A, and the contracted gel 
within the chamber is highlighted by arrow in panel C. (B and D) In the presence of a 
mature monolayer of ARPE-19 cells the collagen gel has not contracted. The 
collagen gel still fills the majority of the apical compartment (above the fibroin 
membrane). The collagen gels were seeded with the exact same number of cells and 
the only difference is the presence or absence of RPE cells. The first study was 
performed in triplicate for each culture set up arrangement.  The scale bar represents 
250 µm and applies to panels A and B. 
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Figure 5.6. Difference in diameter of collagen gels with and without the presence of 
a mature RPE monolayer after 8 days in culture (****p < 0.0001). Data presented 
represents mean (+ standard error of mean) from 5 samples for each culture 
condition.  
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Figure 5.7. Comparison of RF6A cell morphology when grown for 8 days in a 
collagen gel on a fibroin membrane, with or without the presence of a mature RPE 
monolayer. (A) RF6A cells (nuclei; blue) are clumped together with very little 
cytoskeletal morphology seen (F-actin; red), and the collagen gel (green) has been 
pulled tightly around the cells. (B) RF6A cells seeded within collagen gel in the 
presence of a mature RPE monolayer exhibit a relaxed, elongated morphology, 
making connections with neighbouring cells. Area of sample represents 318.20 µm
2
. 
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Figure 5.8. A three-dimensional projection of a mature RPE monolayer (A), grown 
on a fibroin membrane (B, pale blue), with RF6A cells growing within a collagen gel 
underneath (C, green is FITC staining of collagen fibres). Both cell types have F-
actin (red) and nuclei (dark blue) staining. The RPE have taken up some loose FITC 
which can be seen as clumps of green in the cytoplasm of the cells. Area of sample 
equals 318.20 µm
2
 x 120 µm Depth. 
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5.4 DISCUSSION 
The structural and functional changes that occur in Ruysch’s complex with age 
significantly affect the viability and survival of photoreceptors, and ultimately vision. 
Surgical replacement of this complex has shown promise, however issues continue to 
arise in relation to surgical trauma, graft rejection and the persistent pathogenesis and 
natural history of AMD.  
The aim of this study was based on the “bioprosthesis” proposed by Binder et 
al (2007), the development of a cell-based complex that is representative of Ruysch’s 
complex in vivo. We used a fibroin membrane, as a substitute for Bruch’s membrane. 
The fibroin membrane has been shown to have characteristics of a functioning, 
native Bruch’s membrane, including appropriate thickness, permeability and 
mechanical strength, and can also support a functioning monolayer of mature RPE 
cells. In this chapter we demonstrated that the fibroin membrane can support a 
culture of choroidal-derived vascular endothelial cells contained within a collagen 
type I gel. We demonstrated that the fibroin membrane facilitates movement of 
modulating factors between the mature monolayer of the RPE cells and the choroidal 
vascular endothelial cells while keeping a physical barrier between the two cell 
types.  
 In our study we utilised a choroidal vascular endothelial cell line (RF6A) 
derived from Rhesus monkeys. This cell line was selected for preliminary feasibility 
testing prior to extending the study to human primary cells. As with all vascular 
endothelial cells, the RF6A cell cultures benefit from an ECM coating to improve 
attachment and proliferation on the scaffold material. A standard ECM coating is a 
solution called Attachment Factor (AF) which is a proprietary blend of proteins 
containing gelatin which enhances the growth of microvascular endothelial cells. In 
order for the co-culture to be representative of the subretinal architecture, a three 
dimensional gel was used similar to previous studies (Fan et al., 2002; Sakamoto et 
al., 1995).  
A commercial collagen type I (Cellmatrix
®
, Nitta Gelatin Inc.) solution (which 
can be polymerised into a gel) was shown to support microvascular endothelial cell 
growth comparable to AF. When grown in the presence of serum there was no 
difference in total cell numbers after 72 hours when comparing the two ECM 
coatings, and there were no obvious differences in cell morphology. An appropriate 
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morphology was also seen in cells that were suspended within a collagen type I gel. 
The co-cultures created in this study displayed longevity as a three dimensional 
structure throughout the culture period and during processing for confocal 
microscopy. The fibroin membrane acted as a physical barrier between the two cell 
types, yet was able to facilitate some form of communication between the two cell 
types, which was evidenced by the difference in contraction of the collagen gel 
matrix with and without the presence of the mature RPE monolayer. The collagen 
gels were seeded with the same initial number of RF6A cells, however, without the 
presence of a mature monolayer of RPE the collagen gel matrix contracted 
significantly over the 8 day culture period. 
Future studies could investigate the mechanisms and causes for this variation. 
In the presence of a mature RPE monolayer, the RF6A cells may be establishing in a 
more polarised environment and therefore lumen formation is being encouraged 
(Montaño et al., 2010). The RPE secrete both pro- and anti-angiogenic factors, and 
therefore the difference in morphology and collagen matrix contraction may be a 
direct effect of modulating factors being released by the mature RPE monolayer. 
Previous studies have shown RPE cells can mediate effects on choroidal vascular 
endothelial cells (Fan et al., 2002; Sakamoto et al., 1995) which can be inhibited by 
blocking the specific factors. The difference in contraction could be primarily due to 
a difference in RF6A proliferation rate under the two culture conditions, and 
therefore digestion of the collagen gel matrix and quantification of DNA content 
using a Picogreen assay could give a representation of the total cell numbers at 
different time points. This difference would still be modulated by the presence of the 
RPE cells, and further studies could elucidate the cause.  
It would also be interesting to examine the benefits that might be conferred to 
the RPE cells in the co-culture system. Examining the functionality of the RPE cells 
with and without the presence of vascular endothelial cells would give further insight 
to the interactions that occur in Ruysch’s complex and, potentially, the progression 
of disease. In the presence of the vascular endothelial cells there may be a difference 
in protein expression and cellular polarisation of the RPE cells. There may also be 
differences in levels of growth factor secretion and phagocytic ability. A functioning 
Ruysch’s complex relies on communication between the RPE and the choroidal 
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blood supply and issues start to arise and the progression of natural history of AMD 
is often triggered by this communication breakdown.  
 The future evaluation of fibroin membranes in a co-culture complex will need 
to utilise human primary cell sources for both cell types. Currently a fetal source is 
the gold standard RPE cell type (Sonoda et al., 2009; Maminishkis et al., 2006), and 
adult vascular endothelial cells can be isolated and grown in culture using MACS
®
 
sorting, selective cell surface markers, and specialised culture medium (Gillies et al., 
2015). These cell types would provide a more robust evaluation of fibroin 
membranes and allow quantification of the morphological and functional changes 
that occur to human choroidal-derived vascular endothelial cells in the presence of 
RPE cells.  
Ultimately this complex has been designed as a cell-based therapy that with 
further investigation and modification could be used as a graft implant. In evaluating 
its ability to function as an in vivo complex, this co-culture could be used to model 
elements of AMD disease. This could be done by modifying growth factor 
concentrations on either side of the membrane, by introducing toxic substances that 
can cause oxidative damage, and by potentially making changes to the fibroin 
membranes themselves to better represent an aged Bruch’s membrane and study the 
cellular changes that might occur in response. This could be done by increasing 
membrane thickness, reducing membrane permeability, and maybe even by adding a 
lipid component to the fibroin protein. 
5.5 CONCLUSIONS 
In the current study we have shown that fibroin membranes support the co-
culture of RPE cells and choroidal-derived vascular endothelial cells and therefore 
demonstrate potential as a Bruch’s membranes substitute. Significantly, we 
demonstrated that there was a difference in morphology of the choroidal-derived 
vascular endothelial cells when co-cultured in the presence of a mature monolayer of 
RPE cells, and that while the fibroin membranes formed a physical barrier between 
the two cell types, there was evidence of some form of cell-cell communication. 
Future studies will need to employ primary cell sources to confirm and quantify these 
results. If successful, the potential of fibroin membranes as a vehicle for RPE and 
choroidal vascular endothelial cell implants could then be determined in vivo. 
 108 Research Study Three  
 
 
  
 Summary and Future Directions 109 
Chapter 6: Summary and Future Directions 
Many biomaterials have been proposed as a vehicle for RPE cell implantation, 
and as a material for repairing Bruch’s membrane. None of these biomaterials, 
however, currently fulfil the range of specific structural and functional criteria of 
Bruch’s membrane. The purpose of this project was therefore to evaluate fibroin as a 
possible Bruch’s membrane substitute. In an effort to engineer a tissue construct that 
resembles the three tissue layers of Ruysch’s complex, this project was designed with 
three separate but closely linked studies. I evaluated the functionality of RPE cells 
grown on fibroin membranes, evaluated the feasibility of modifying fibroin 
membranes to include ECM components vital to the native structure of Bruch’s 
membrane, and established a co-culture model of Ruysch’s complex in vitro. 
6.1 FUNCTIONALITY OF RPE CELLS ON FIBROIN MEMBRANES 
The first study represents the first time the growth of mature cultures of RPE 
cells on fibroin and commercial polyester membranes have been directly compared. 
My findings demonstrate that RPE cells can develop functionality on fibroin 
comparable to the commercial polyester membranes. Specifically, cultures 
established on either material developed a cobblestoned morphology with partial 
pigmentation within 12 weeks, and evaluation after 16 weeks in culture revealed that 
the cultures grown on fibroin displayed a rounder apical surface with a more dense 
distribution of microvilli-like projections. RPE cultures grown on either membrane 
were able to demonstrate appropriate localisation of RPE specific cytoplasmic and 
membrane-bound protein distribution, selective phagocytosis and polarised growth 
factor secretion. The morphology and functionality of the RPE cells that has been 
achieved in this study suggest that fibroin may be an appropriate substitute for 
Bruch’s membrane.  
A major limitation of this study, however, is the use of the immortalised RPE 
cell line, ARPE-19, which cannot be used in human transplantation. Compounding 
this issue is the contradictory results that have been reported using this cell source. 
Most reported results for ARPE-19 cells have been collected from immature cultures 
often before they reached confluency, let alone maturation. This problem has been 
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multiplied when culture medium formulations have been used in combination with 
inappropriate levels of CO2 in cell culture incubators, and by not employing 
suspended culture substrates that allow an apical-basal polarisation of the culture 
(Pfeffer & Philp, 2014). It is acknowledged that there are distinct differences in 
ARPE-19 cells when compared to native RPE cells, for example, the inability to 
complete the formation of functioning tight junction complexes (Luo et al., 2006), 
however, if the cells are grown with best standard practice, ARPE-19 cultures can be 
useful in evaluating approximate RPE morphology and functionality. Nevertheless, a 
more appropriate source of human RPE cells, such as primary fetal RPE cells, or 
iPS-derived RPE cells will need to be used to further evaluate the potential of fibroin 
membranes. 
Looking to the future, the implantation of fibroin membranes into the 
subretinal space of an animal model to study safety, efficacy and surgical handling is 
necessary. Understanding the immunogenicity and degradation rate of fibroin 
membranes in the subretinal space are of vital importance for advancement to a pre-
clinical study in combination with RPE cells. The commercial polyester membranes 
have supported the implantation of human RPE cells into the subretinal space of a 
rabbit model (Stanzel et al., 2014), however, the permeability, rigidity, and perhaps 
thickness of the polyester membranes resulted in the death of the overlying host 
photoreceptor cells, regardless of implanted RPE cell survival. It was suggested that 
the transport of nutrients and waste with the underlying choroidal blood supply was 
interrupted by the presence of the polyester membrane. Theoretically the fibroin 
membrane should be well tolerated in the subretinal space as it is immunologically 
inert, and silk sutures have been used in the human body for centuries. Eventually the 
implantation of fibroin membranes with a monolayer of RPE cells, under the macula, 
with and without removing the equivalent areas of host tissue will be the ultimate test 
of viability. 
6.2 INCORPORATING AN ELASTIN COMPONENT IN FIBROIN 
MEMBRANES 
Considering the elastin-rich core of Bruch’s membrane I proposed that fibroin 
membranes may provide a vehicle for co-delivering RPE cells as well as ECM 
components to the subretinal space. The feasibility of incorporating recombinant 
human tropoelastin, which displays similar elastic properties to elastin, into the 
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fibroin membranes was confirmed, and RPE cell responses (attachment and growth) 
to fibroin membranes was not affected by the presence of tropoelastin. Membranes 
prepared using a sequential layering method (fibroin-tropoelastin-fibroin) achieved a 
homogenous distribution of tropoelastin and fibroin. It was subsequently proposed 
that this result was due to absorption and subsequent fixation (by treatment with 
methanol) of tropoelastin within the originally cast fibroin membrane. In 
comparison, membranes prepared from blended solutions of the two proteins 
displayed a more heterogeneous composition, with the patchy distribution most 
likely resulting from either phase separation or specific molecular interactions 
between the two proteins when present together in solution.  
While others have reported reduced stiffness of fibroin membranes following 
inclusion of tropoelastin (via blending in solution) (Hu et al., 2011, 2010), we 
reported the opposite result. A close comparison of the methods used, however, 
revealed several significant variations including the source of cocoons, fibroin 
protein isolation protocol, water annealing temperature and the thickness of 
membranes used. In our experience, any one of the parameters alone can have 
significant effects on the properties of fibroin membranes. Thus in combination, the 
differing processes could well have been responsible for the variations in response to 
the tropoelastin observed between each study. It is thus significant that our standard 
fibroin membranes and membranes prepared using the layered approach are closest 
to native Bruch's membrane in terms of Young’s modulus (Curcio & Johnson, 2013).  
While loading of tropoelastin into fibroin membranes has been demonstrated, it 
remains to be seen if the tropoelastin will be released and converted to elastin by the 
RPE cells. An in vitro model of the elastic fiber assembly process demonstrated that 
RPE cells are able of converting tropoelastin into elastic fibers, using endogenous 
microfibrils and lysyl oxidase (Wachi et al., 2005). Although, this study used semi-
confluent ARPE-19 cells, it was quite clear that the integration of exogenous 
tropoelastin provided to the cells via the culture medium was actively incorporated 
into the ECM of the RPE cultures. It is unknown if the tropoelastin provided to the 
RPE cells within the fibroin membranes will be converted in a similar way. It is also 
unknown if processing of the tropoelastin by methanol treatment will reduce its 
bioavailability to the elastic fiber assembly process. Regardless, further studies may 
elucidate new understanding of the interaction between the two proteins, and the 
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mechanisms of the apparent absorption of the tropoelastin protein into the initially 
cast fibroin layer. Modifying the layered approach and testing new methods of 
stabilising the tropoelastin protein (other than methanol “fixation”) may improve the 
mechanical properties, and potentially, the conversion of tropoelastin. Further studies 
would also need to examine the differences in degradation rate, and whether the 
presence of the tropoelastin will alter this turnover and perhaps promote the 
development of a new native Bruch’s membrane structure, when compared to the 
fibroin membranes alone (George et al., 2013). 
A further consideration when using recombinant human tropoelastin is the cost 
of the protein, which is in stark contrast to the relatively cheap isolation of the fibroin 
protein. Without the kind gift of the tropoelastin protein from our collaborator, 
Professor Tony Weiss, this study would have been prohibitively expensive. 
Preliminary studies were performed using a cheaper elastin protein from a bovine 
source, however, the resulting membranes were extremely fragile and unsuitable for 
further evaluation. It is unknown whether the theoretical benefits of including ECM 
components in the RPE-fibroin membrane complex, and therefore in the subretinal 
space upon implantation, would offset this significant additional cost of production. 
6.3 CO-CULTURE OF RPE AND CHOROIDAL VASCULAR 
ENDOTHELIAL CELLS EITHER SIDE OF FIBROIN MEMBRANE 
Due to the complexity of the macula and complications of human ageing, 
surgical replacement of RPE cells and reconstruction of the subretinal architecture is 
yet to be resolved in humans. The inspiration for the final study was the novel 
approach proposed by Binder et al. (2007) in which they described a complex that 
would be most like the native structure of Ruysch’s complex, and could potentially 
anchor into the patient’s vasculature upon implantation. The main goal was to 
evaluate the ability to use fibroin membranes as a substitute for Bruch’s membrane in 
the creation of a co-culture complex of RPE cells and choroidal-derived vascular 
endothelial cells. I was able to demonstrate that the fibroin membrane acted as a 
physical barrier between the two cell types, while facilitating communication 
between the mature monolayer of RPE cells and the choroidal-derived vascular 
endothelial cells as demonstrated by differences in vascular endothelial cell 
morphology. The fibroin membrane, suspended in our custom-designed culture 
chamber, was able to support a three-dimensional collagen gel for the entirety of the 
 Summary and Future Directions 113 
culture period and the co-culture complex could be described as being an in vitro 
representation of the subretinal architecture. Within the timeframe of this doctoral 
project, the mechanisms of interaction between the two cell types and their 
interaction with the fibroin membrane were not elucidated. Regardless, as only cell 
line cultures were used and a primate vascular endothelial cell line at that, this 
complex would need to be recreated with primary human cell sources before 
proceeding with further investigation. 
Future investigations of this co-culture complex should focus on refinement of 
the culture system and measuring cell function and mechanisms of cell to cell 
interaction. The use of this co-culture complex as a model of AMD disease will 
likely be the ultimate test of function, prior to pre-clinical trials. It is possible this co-
culture complex might also provide enlightenment on the potential regeneration of a 
new Bruch’s membrane in vivo. It is known that both the RPE cells and the choroidal 
vasculature are able to produce individual components of Bruch’s membrane and 
during embryonic development the ECM structure is formed between these two cell 
layers (Booij et al., 2010). However, to the best of my knowledge this process has 
not been demonstrated in vitro, and certainly not in vivo postnatal. The theoretical 
potential of implanted RPE cells to reconstruct a Bruch’s membrane structure in an 
aged patient is a cornerstone of most RPE transplantation ideas. Further refinement 
and development of this co-culture complex could provide insights into the 
contribution of the RPE and choroidal vascular endothelial cells in the re-creation of 
Bruch’s membrane, with the fibroin membrane acting as a tissue framework, and the 
presence of tropoelastin perhaps providing an advantage. 
6.4 CONCLUSION 
In this PhD project, I have investigated the potential of using fibroin 
membranes as a Bruch’s membrane substitute in the context of RPE cell 
transplantation. This project demonstrated the functionality of RPE cells grown on 
fibroin membranes, the feasibility of incorporating a native Bruch’s membrane ECM 
component in the fibroin membranes, and the effect of co-culturing vascular cells in 
this system. The tissue engineered complex is in many ways comparable to Ruysch’s 
complex, however considerable future efforts will be required to create an implant 
suitable for human patients. The outcomes of this thesis provide a foundation for the 
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use of fibroin membranes as a Bruch’s membrane substitute and offer a stepping 
stone for future studies in RPE transplantation. 
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